GO,Function,Proteins,Gene Name,Ontology group,Count of protein,Number of proteins detected within the genome,GO frequency within the dataset (%),GO frequency within the genome (%),P-Value,P-Values_BH
GO:0005576,extracellular region,A7MB70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q28019(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)Q8MJ24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q3SWW8(Evidence code:IEA/Database source:InterPro:IPR008859)P50291(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens)P17453(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q17QK3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P56652(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q9MYY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A1A4K5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q32L50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P21793(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A5D7V3(Evidence code:IEA/Database source:InterPro:IPR000867)Q05443(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BPW0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)O19116(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P19879(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BF81(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P98140(Evidence code:IEA/Database source:InterPro:IPR000083)A7YWG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P49259(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q05717(Evidence code:IEA/Database source:InterPro:IPR000867|I)Q2KJ63(Evidence code:IEA/Database source:InterPro:IPR000177)O18739(Evidence code:IEA/Database source:InterPro:IPR000867)Q95M17(Evidence code:IEA/Database source:InterPro:IPR002557)A6QLI0(Evidence code:IEA/Database source:InterPro:IPR001299)E1BI98(Evidence code:IEA/Database source:UniProtKB:P12109|ens)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A6QL48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P49907(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BG25(Evidence code:IEA/Database source:InterPro:IPR018195)A2VE29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A5PKI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)F1MW38(Evidence code:IEA/Database source:InterPro:IPR000867)P00743(Evidence code:IEA/Database source:InterPro:IPR000294|I)G3MYZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A5D7S8(Evidence code:IEA/Database source:InterPro:IPR000020), SEMA3C LTBP2 PPT1 LOXL4 THBS4 FST CLSTN1 BPI CPQ BMP3 ITIH3 HPSE ENPP2 SBSPON DCN ANG2 ESM1 LUM GALNT1 ENTPD5 SFRP1 OGN SERPINA6 FURIN F12 GGH PLA2R1 IGFBP5 KLKB1 CTGF CHIA EPDR1 COL6A1 MMP2 IL34 SELENOP MELTF ITIH5 FAM3C CRIM1 F10 AFM FBLN1,CC,43,43 of 300,24.86,14.33,4.116E-42,3.816E-39
GO:0005615,extracellular space,Q05717(Evidence code:IBA/Database source:PANTHER:PTN000167605)O19116(Evidence code:IDA/Database source:)P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens)A5PJ69(Evidence code:IEA/Database source:InterPro:IPR000215)F1MG91(Evidence code:IEA/Database source:InterPro:IPR000215)A3KLR9(Evidence code:IEA/Database source:UniProtKB:O09164|ens)A6QL48(Evidence code:IEA/Database source:InterPro:IPR020415)P17453(Evidence code:IEA/Database source:InterPro:IPR030675)A7YWG4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q9Y646)G3MYZ3(Evidence code:IEA/Database source:InterPro:IPR000264|I)Q5BIR5(Evidence code:IEA/Database source:InterPro:IPR000215)A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens)E1BG25(Evidence code:IEA/Database source:InterPro:IPR016357)Q5EA85(Evidence code:IBA/Database source:PANTHER:PTN000744245)F1MEW1(Evidence code:IBA/Database source:PANTHER:PTN000744245)Q9XSC6(Evidence code:ISS/Database source:UniProtKB:P00565)Q2KJ63(Evidence code:IEA/Database source:UniProtKB:P03952|ens)Q2KJ64(Evidence code:IEA/Database source:UniProtKB:P05089|ens)G3X6G7(Evidence code:IEA/Database source:UniProtKB:Q8VE43|ens)P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)G8JKW7(Evidence code:IEA/Database source:InterPro:IPR000215)A1A4K5(Evidence code:ISS/Database source:UniProtKB:Q13822)A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens)A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens)Q95M17(Evidence code:ISS/Database source:UniProtKB:Q9BZP6)Q8MJ24(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P98140(Evidence code:IEA/Database source:InterPro:IPR014394)E1BF81(Evidence code:IEA/Database source:InterPro:IPR000215)Q3SYW7(Evidence code:IEA/Database source:InterPro:IPR001999)P19879(Evidence code:IBA/Database source:PANTHER:PTN001224703)E1BIR5(Evidence code:IEA/Database source:UniProtKB:O75339|ens)Q17QB3(Evidence code:IEA/Database source:UniProtKB:Q13510|ens)A5PK77(Evidence code:IEA/Database source:InterPro:IPR000215)Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens)Q05443(Evidence code:IBA/Database source:PANTHER:PTN001224703)Q0VCU3(Evidence code:IBA/Database source:PANTHER:PTN000274640), IGFBP5 SFRP1 CTSL SERPINA10 SERPINB2 ECSOD IL34 BPI GGH THBS4 CPQ AFM SERPINB8 SEMA3C MELTF SEMA4A SEMA3A CKM KLKB1 ARG1 METRNL BMP3 SERPINA3 ENPP2 LMAN2 SEMA4D CHIA LOXL4 F12 SERPINA6 SPARCL1 OGN CILP ASAH1 SERPINA11 LCAT LUM CTSF,CC,38,38 of 426,21.97,8.92,1.233E-30,5.716E-28
GO:0016020,membrane,Q9GKR2(Evidence code:IEA/Database source:InterPro:IPR003987|I)F1MFJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9MYM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BEC6(Evidence code:IEA/Database source:InterPro:IPR008078)A5D7C8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7E335(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q2TBL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QLT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MME1(Evidence code:IEA/Database source:InterPro:IPR000998)F1MJV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1ME65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MNL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MS76(Evidence code:IEA/Database source:UniProtKB:Q8C341|ens)A5PKH0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9TTK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MMI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BKZ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P00514(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B8L8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1ML49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N780(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QP36(Evidence code:IEA/Database source:InterPro:IPR005052)Q2HJD1(Evidence code:IEA/Database source:InterPro:IPR005052)F1MCA2(Evidence code:IEA/Database source:InterPro:IPR002126|I)O62829(Evidence code:ISS/Database source:UniProtKB:P49443)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BBP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q8MJ24(Evidence code:IEA/Database source:InterPro:IPR001190|I)G3MY87(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens)F1N2J8(Evidence code:IEA/Database source:UniProtKB:Q6UX73|ens)A7Z047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MD95(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q769I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MWN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BJP8(Evidence code:IEA/Database source:InterPro:IPR002126|I)F1ML75(Evidence code:IEA/Database source:UniProtKB:P14778|ens)A5PJN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)O62830(Evidence code:ISS/Database source:UniProtKB:P36993)E1B969(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q3T083(Evidence code:IEA/Database source:InterPro:IPR016093|I)Q5E9X0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P17453(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N283(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9MYY0(Evidence code:IEA/Database source:InterPro:IPR005199)Q1ZYR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QLR1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BKQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VC16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P49259(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KIW4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2TBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BD40(Evidence code:IEA/Database source:InterPro:IPR002126|I)F1MW38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5EA01(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DN1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MS00(Evidence code:IEA/Database source:InterPro:IPR002126|I), VCAM1 PTPRG ERAP2 GAA SEMA4A ADGRF1 SEMA4D CDH16 CADM1 FOLH1 PTPRK ADGRG6 CKAP4 FURIN NEO1 SUCO TOR1AIP2 AOC3 LRRC15 SORT1 PRKAR1A FCAMR KIAA0319L EPHA7 LMAN2 LMAN2L PCDHGB1 PPM1A GALNT1 ST8SIA1 GALNT3 LOXL4 MGAM ERO1B C16orf89 TMEM132A CLSTN1 MET GOLIM4 PCDHGA7 IL1R1 ERO1A  COLEC12 PPM1B DCHS1 SDF2L1 GFRA2 BPI XXYLT1 HPSE CLN5 PVRL4 GALNT5 LDLR GPC3 MIA3 PLA2R1 MMP2 LCAT MGC133692 PCDHGB2 CRIM1 B4GAT1  TNFRSF21 RET,CC,65,65 of 1837,37.57,3.54,1.329E-27,4.107E-25
GO:0016021,integral component of membrane,Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MFJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B969(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KIW4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2TBL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MY87(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MNL4(Evidence code:IEA/Database source:InterPro:IPR010560)E1BKQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2HJD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MD95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)F1MME1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N780(Evidence code:IEA/Database source:InterPro:IPR001426)F1MJV6(Evidence code:IEA/Database source:InterPro:IPR000832|I)A5PKH0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7Z047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9GKR2(Evidence code:IEA/Database source:InterPro:IPR008424)F1ML49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9TTK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BD40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BEC6(Evidence code:IEA/Database source:InterPro:IPR000832|I)A7E335(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QLT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2TBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QLR1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q769I5(Evidence code:IEA/Database source:InterPro:IPR016244)Q5EA01(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1ME65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)O19116(Evidence code:IBA/Database source:PANTHER:PTN000139394)Q08DN1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BJP8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BKZ9(Evidence code:IEA/Database source:InterPro:IPR006581)A6QP36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MMI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MWN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P49259(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BBP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N283(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MW38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MCA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B8L8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812), ST8SIA1 PTPRG DCHS1 LCAT CADM1 MGAM NEO1 GALNT5 LMAN2L CLSTN1 CLN5 PTPRK EPHA7 ADGRG6 TOR1AIP2 TMEM132A VCAM1 KIAA0319L MIA3 GALNT1 AOC3 PCDHGB2 COLEC12 ADGRF1 CDH16 FOLH1 MGC133692 PVRL4 SEMA4A MET B4GAT1  CKAP4 SFRP1 TNFRSF21 PCDHGA7 SORT1 LMAN2 LDLR LRRC15 GOLIM4 PLA2R1 FURIN GALNT3 ERAP2 XXYLT1 CRIM1 PCDHGB1 FCAMR,CC,48,48 of 1299,27.75,3.7,4.016E-22,9.308E-20
GO:0016787,hydrolase activity,Q0VD27(Evidence code:IEA/Database source:InterPro:IPR006439)Q9MYY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BPW0(Evidence code:IEA/Database source:InterPro:IPR000407)Q17QB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0V8B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P46446(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR001604|I)P98140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q17QX0(Evidence code:IEA/Database source:InterPro:IPR000086|I)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q95M12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q9MYM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P25975(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2KJ64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6H713(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MME1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q29444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)O62830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)O62829(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P00743(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A7MBC0(Evidence code:IEA/Database source:InterPro:IPR006680)P56965(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2T9S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A7MBI8(Evidence code:IEA/Database source:InterPro:IPR000086|I)P45478(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A7YWG4(Evidence code:IEA/Database source:InterPro:IPR011697)F1MFJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3T0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q17QK3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378), ENOPH1 HPSE ENTPD5 ASAH1 TPP1 ASPA ENPP2 F12 NUDT5 ERAP2 LGMN GAA CTSL KLKB1 ARG1 LIPA PTPRK MANBA PPM1B ANG2 PPM1A F10 AMDHD2 DDAH1 PGP CHIA NUDT9 PPT1 GGH PTPRG CES2 MMP2 FURIN CPQ,MF,34,34 of 836,19.65,4.07,1.128E-17,1.77E-15
GO:0005882,intermediate filament,A6QQQ9(Evidence code:IEA/Database source:InterPro:IPR001664)Q148H8(Evidence code:IEA/Database source:InterPro:IPR001664)A6QP32(Evidence code:IEA/Database source:InterPro:IPR001664)A3KMY1(Evidence code:IEA/Database source:InterPro:IPR001664)Q2KI75(Evidence code:IEA/Database source:InterPro:IPR001664)A5PJJ1(Evidence code:IEA/Database source:InterPro:IPR001664)F1MXG6(Evidence code:IEA/Database source:InterPro:IPR001664)A7YWM2(Evidence code:IEA/Database source:InterPro:IPR001664)A4FUZ0(Evidence code:IEA/Database source:InterPro:IPR001664)A1A4M3(Evidence code:IEA/Database source:InterPro:IPR001664)Q148J0(Evidence code:IEA/Database source:InterPro:IPR001664)F1MSQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0403)G3X7V4(Evidence code:IEA/Database source:InterPro:IPR001664), KRT20 KRT72 KRT85 KRT82 KRT222 KRT33A LOC618455 KRT40 KRT83 KRT86 KRT34 NEFH LOC787600,CC,13,13 of 45,7.51,28.89,1.146E-17,1.77E-15
GO:0005509,calcium ion binding,E1BD40(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1B969(Evidence code:IEA/Database source:InterPro:IPR002126|I)A1A4K5(Evidence code:ISS/Database source:UniProtKB:Q13822)E1BBP1(Evidence code:IEA/Database source:UniProtKB:Q14435|ens)F1MCA2(Evidence code:IEA/Database source:InterPro:IPR002126|I)P98140(Evidence code:IEA/Database source:InterPro:IPR001881)E1BJP8(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q28019(Evidence code:IEA/Database source:InterPro:IPR001881|I)A7E335(Evidence code:IEA/Database source:InterPro:IPR002126|I)P01131(Evidence code:IEA/Database source:InterPro:IPR001881|I)P00743(Evidence code:IEA/Database source:InterPro:IPR000294|I)F1MS00(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q3SYW7(Evidence code:IEA/Database source:InterPro:IPR002048|I)E1BA44(Evidence code:IEA/Database source:InterPro:IPR001881|I)A6QLI0(Evidence code:IEA/Database source:InterPro:IPR001299)A5D7S8(Evidence code:IEA/Database source:InterPro:IPR001881|I)F1MD95(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q3SWW8(Evidence code:IEA/Database source:InterPro:IPR001881|I)E1BIY5(Evidence code:IEA/Database source:InterPro:IPR014615), PCDHGB2 DCHS1 ENPP2 GALNT3 PCDHGB1 F12 PCDHGA7 LTBP2 CDH16 LDLR F10 RET SPARCL1 LTBP4 EPDR1 FBLN1 CLSTN1 THBS4 SULF2,MF,19,19 of 203,10.98,9.36,8.198E-17,9.5E-15
GO:0005764,lysosome,Q1ZYR0(Evidence code:IEA/Database source:InterPro:IPR026138)A6QLI0(Evidence code:IEA/Database source:UniProtKB:Q99M71|ens)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q6IRK9)P01131(Evidence code:ISS/Database source:UniProtKB:P01130)Q0VCU3(Evidence code:IBA/Database source:PANTHER:PTN000274640)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)Q17QB3(Evidence code:IEA/Database source:InterPro:IPR016699)A7YWG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)P25975(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q29444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q0V8B6(Evidence code:ISS/Database source:UniProtKB:O14773)Q95M12(Evidence code:ISS/Database source:UniProtKB:O89017)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)Q9MYM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q9MYY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458), CLN5 EPDR1 CPQ LDLR CTSF GPC3 ASAH1 GGH CTSL MANBA TPP1 LGMN PPT1 GAA HPSE,CC,15,15 of 93,8.67,16.13,8.108E-17,9.5E-15
GO:0005886,plasma membrane,A6QLR1(Evidence code:IEA/Database source:UniProtKB:K4PZ75|ens)E1BEC6(Evidence code:IEA/Database source:UniProtKB:Q8VEC3|ens)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A7E335(Evidence code:IEA/Database source:InterPro:IPR020894|I)F1MNL4(Evidence code:IEA/Database source:UniProtKB:Q92859|ens)P49259(Evidence code:ISS/Database source:UniProtKB:Q13018)P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P00570(Evidence code:IEA/Database source:UniProtKB:Q9R0Y5|ens)A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000164501)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)Q2TBL2(Evidence code:IEA/Database source:UniProtKB:Q9BY67|ens)F1MCA2(Evidence code:IEA/Database source:InterPro:IPR020894)F1MS00(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)G3MXM5(Evidence code:IEA/Database source:UniProtKB:P54826|ens)Q9TTK6(Evidence code:ISS/Database source:UniProtKB:Q16853)O19116(Evidence code:IDA/Database source:)Q5E9X0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P00514(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1B969(Evidence code:IEA/Database source:InterPro:IPR020894)A5D7C8(Evidence code:IBA/Database source:PANTHER:PTN000112375)F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q86SQ4|ens)E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens)E1BJP8(Evidence code:IEA/Database source:InterPro:IPR020894)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MYJ3(Evidence code:IEA/Database source:UniProtKB:Q9Z2A9|ens)E1BD40(Evidence code:IEA/Database source:InterPro:IPR020894)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), PVRL4 ADGRF1 SEMA4A CDH16 NEO1 PLA2R1 LDLR AK1 ERAP2 SORT1 PTPRK CADM1 PCDHGB1 RET GAS1 AOC3 SFRP1 GFRA2 PRKAR1A DCHS1 SEMA4D ADGRG6 SULF2 PCDHGA7 FURIN GGT5 PCDHGB2 GPC3,CC,28,28 of 630,16.18,4.44,7.03E-16,7.241E-14
GO:0005794,Golgi apparatus,Q5EA01(Evidence code:ISS/Database source:UniProtKB:O43505)Q2HJD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens)E1BKQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)E1BBP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BIY5(Evidence code:IEA/Database source:InterPro:IPR014615)Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BKK9(Evidence code:IEA/Database source:UniProtKB:Q8VHC3|ens)P01131(Evidence code:ISS/Database source:UniProtKB:P01130)A5PKI3(Evidence code:IEA/Database source:UniProtKB:Q92520|ens)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BKZ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q6IRK9)F1MNL4(Evidence code:IEA/Database source:UniProtKB:Q92859|ens)Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333), B4GAT1  LMAN2L LMAN2 GALNT5 PPT1 GALNT3 SULF2 CLN5 GALNT1 SELENOM LDLR FAM3C FURIN SORT1 CPQ NEO1 ST8SIA1,CC,17,17 of 202,9.83,8.42,1.556E-14,1.443E-12
GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,F1MD95(Evidence code:IEA/Database source:InterPro:IPR002126)E1BJP8(Evidence code:IEA/Database source:InterPro:IPR002126)A7E335(Evidence code:IEA/Database source:InterPro:IPR002126)F1MS00(Evidence code:IEA/Database source:InterPro:IPR002126)Q2TBL2(Evidence code:IBA/Database source:PANTHER:PTN000589024)E1BD40(Evidence code:IEA/Database source:InterPro:IPR002126)F1MCA2(Evidence code:IEA/Database source:InterPro:IPR002126)E1B969(Evidence code:IEA/Database source:InterPro:IPR002126), CLSTN1 PCDHGA7 CDH16 RET CADM1 PCDHGB2 PCDHGB1 DCHS1,BP,8,8 of 16,4.62,50,5.389E-13,4.541E-11
GO:0010951,negative regulation of endopeptidase activity,F1MG91(Evidence code:IEA/Database source:GO:0004867)F1MW38(Evidence code:IEA/Database source:GO:0004867)A2VE29(Evidence code:IEA/Database source:GO:0004867)Q5BIR5(Evidence code:IEA/Database source:UniProtKB:P50452|ens)P56652(Evidence code:IEA/Database source:GO:0004867)A5PJ69(Evidence code:IEA/Database source:GO:0004867)A5PK77(Evidence code:IEA/Database source:GO:0004867)E1BF81(Evidence code:IEA/Database source:GO:0004867)G8JKW7(Evidence code:IEA/Database source:GO:0004867), SERPINB2 CRIM1 ITIH5 SERPINB8 ITIH3 SERPINA10 SERPINA11 SERPINA6 SERPINA3,BP,9,9 of 31,5.2,29.03,1.038E-12,8.022E-11
GO:0006508,proteolysis,Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q9Y646)I2E4T6(Evidence code:IEA/Database source:GO:0004252)A8E4N2(Evidence code:IEA/Database source:InterPro:IPR001254)A6QPT7(Evidence code:IEA/Database source:InterPro:IPR001930)A7YWG4(Evidence code:IEA/Database source:GO:0034722)Q95M12(Evidence code:IEA/Database source:InterPro:IPR001096)P25975(Evidence code:IEA/Database source:InterPro:IPR000668)Q0V8B6(Evidence code:IEA/Database source:InterPro:IPR030400|I)F1MYJ3(Evidence code:IEA/Database source:UniProtKB:P36269|ens)Q0VCU3(Evidence code:IEA/Database source:InterPro:IPR000668)P00743(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q9GLE5(Evidence code:IEA/Database source:InterPro:IPR001818|I)P98140(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q2KJ63(Evidence code:IEA/Database source:InterPro:IPR000177|I)Q28193(Evidence code:IEA/Database source:InterPro:IPR000209|I)F1N1S6(Evidence code:IEA/Database source:InterPro:IPR001254|I), CPQ MASP2 MASP1 ERAP2 GGH LGMN CTSL TPP1 GGT5 CTSF F10 MMP2 F12 KLKB1 FURIN C1RL,BP,16,16 of 230,9.25,6.96,1.322E-12,9.429E-11
GO:0030246,carbohydrate binding,A6QP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)E1BBP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)Q9MYM4(Evidence code:IEA/Database source:InterPro:IPR011013)A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens)E1BKQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)Q2HJD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)G3MY87(Evidence code:IEA/Database source:InterPro:IPR011013)P49259(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)I2E4T6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens), COLEC12 GALNT3 GALNT1 GAA LMAN2 GALNT5 LMAN2L MGAM PLA2R1 MASP2 CNTN2,MF,11,11 of 73,6.36,15.07,1.799E-12,1.191E-10
GO:0007399,nervous system development,E1BD40(Evidence code:IBA/Database source:PANTHER:PTN001932250)Q0V8B6(Evidence code:ISS/Database source:UniProtKB:O14773)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)E1BJP8(Evidence code:IBA/Database source:PANTHER:PTN001932250)F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens)F1MNL4(Evidence code:IEA/Database source:InterPro:IPR033024)A7MB70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)E1BPC9(Evidence code:IEA/Database source:InterPro:IPR032991), PCDHGB2 TPP1 SEMA4A PCDHGA7 RET NEO1 SEMA3C PPT1 CNTN2,BP,9,9 of 36,5.2,25,3.281E-12,2.028E-10
GO:0007155,cell adhesion,A6QLR1(Evidence code:IEA/Database source:InterPro:IPR033320)F1MCA2(Evidence code:IEA/Database source:InterPro:IPR020894)E1BJP8(Evidence code:IEA/Database source:InterPro:IPR020894)Q9TTK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)Q3SWW8(Evidence code:IEA/Database source:InterPro:IPR003367|I)Q9MYY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)A7E335(Evidence code:IEA/Database source:InterPro:IPR020894)F1MS00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)Q9GKR2(Evidence code:IEA/Database source:InterPro:IPR008424)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)Q28161(Evidence code:IEA/Database source:InterPro:IPR028432)E1B969(Evidence code:IEA/Database source:InterPro:IPR020894)E1BD40(Evidence code:IEA/Database source:InterPro:IPR020894)O18739(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130), PVRL4 PCDHGB1 PCDHGA7 AOC3 THBS4 HPSE CDH16 RET VCAM1 PTPRK PKP1 DCHS1 PCDHGB2 CTGF,BP,14,14 of 171,8.09,8.19,4.03E-12,2.335E-10
GO:0004867,serine-type endopeptidase inhibitor activity,P56652(Evidence code:IEA/Database source:InterPro:IPR010600)A5PK77(Evidence code:IBA/Database source:PANTHER:PTN000156122)Q5BIR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0722)G8JKW7(Evidence code:IBA/Database source:PANTHER:PTN000156122)A5PJ69(Evidence code:IBA/Database source:PANTHER:PTN000156122)F1MG91(Evidence code:IEA/Database source:InterPro:IPR015556)F1MW38(Evidence code:IEA/Database source:InterPro:IPR004094)E1BF81(Evidence code:IBA/Database source:PANTHER:PTN000156122)A2VE29(Evidence code:IEA/Database source:InterPro:IPR010600), ITIH3 SERPINA11 SERPINB8 SERPINA3 SERPINA10 SERPINB2 CRIM1 SERPINA6 ITIH5,MF,9,9 of 43,5.2,20.93,1.315E-11,7.17E-10
GO:0009986,cell surface,A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens)P01131(Evidence code:ISS/Database source:UniProtKB:P01130)E1BG25(Evidence code:IEA/Database source:UniProtKB:P08582|ens)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens)F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens)F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens)E1BIY5(Evidence code:IEA/Database source:InterPro:IPR014615)P49259(Evidence code:IEA/Database source:UniProtKB:Q13018|ens)Q9TTK6(Evidence code:ISS/Database source:UniProtKB:Q16853), LMAN2 PTPRK SORT1 LDLR MELTF CNTN2 IL1R1 CLSTN1 SULF2 PLA2R1 AOC3,CC,11,11 of 94,6.36,11.7,2.163E-11,1.114E-09
GO:0005783,endoplasmic reticulum,E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9)Q0VC16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A5PJN2(Evidence code:IEA/Database source:InterPro:IPR007266|I)A5PKH0(Evidence code:IEA/Database source:UniProtKB:A0A024R957)Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)F1ME65(Evidence code:IEA/Database source:UniProtKB:Q07065|ens)Q3T083(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q2HJD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)E1BKK9(Evidence code:IEA/Database source:UniProtKB:Q8VHC3|ens)Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2)A6QPT7(Evidence code:IEA/Database source:InterPro:IPR033528)E1BIY5(Evidence code:IEA/Database source:InterPro:IPR014615)F1MW08(Evidence code:IEA/Database source:InterPro:IPR007266|I)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q6IRK9), ENTPD5 MIA3 ERO1A  TOR1AIP2 CLN5 CKAP4 SDF2L1 LMAN2L SELENOM THBS4 ERAP2 SULF2 ERO1B CPQ,CC,14,14 of 220,8.09,6.36,9.263E-11,4.519E-09
GO:0006898,receptor-mediated endocytosis,Q8MJ24(Evidence code:IEA/Database source:GO:0005044)P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens)Q32L50(Evidence code:IEA/Database source:GO:0005044)Q864Z4(Evidence code:IEA/Database source:GO:0030229)G3MYM8(Evidence code:IEA/Database source:GO:0005044)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)A1A4K5(Evidence code:IEA/Database source:GO:0005044)P49259(Evidence code:ISS/Database source:UniProtKB:Q13018-1), LOXL4 LDLR SBSPON vldlr PRG4 PPT1 ENPP2 PLA2R1,BP,8,8 of 36,4.62,22.22,1.175E-10,5.448E-09
GO:0016757,"transferase activity, transferring glycosyl groups",Q95KW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)E1BBP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)E1BKQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q5EA01(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)A5PJH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)F1N283(Evidence code:IEA/Database source:InterPro:IPR002495)Q29RN2(Evidence code:IEA/Database source:InterPro:IPR002495), ART3 GALNT3 GALNT1 ST8SIA1 GALNT5 B4GAT1  UPP1 XXYLT1 GYG1,MF,9,9 of 69,5.2,13.04,5.714E-10,2.432E-08
GO:0050919,negative chemotaxis,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens)Q5EA85(Evidence code:IBA/Database source:PANTHER:PTN000744245)F1N780(Evidence code:IEA/Database source:GO:0045499)A5D7C8(Evidence code:IBA/Database source:PANTHER:PTN000744245)A7MB70(Evidence code:IBA/Database source:PANTHER:PTN000744245), SEMA3A SEMA4A EPHA7 SEMA4D SEMA3C,BP,5,5 of 4,2.89,125,5.773E-10,2.432E-08
GO:0045095,keratin filament,A6QP32(Evidence code:IEA/Database source:InterPro:IPR003054)A3KMY1(Evidence code:IEA/Database source:InterPro:IPR003054)A1A4M3(Evidence code:IEA/Database source:InterPro:IPR003054)G3X7V4(Evidence code:IEA/Database source:InterPro:IPR003054)A4FUZ0(Evidence code:IEA/Database source:InterPro:IPR003054)Q148H8(Evidence code:IEA/Database source:InterPro:IPR003054), KRT85 KRT82 KRT86 LOC787600 KRT83 KRT72,CC,6,6 of 17,3.47,35.29,2.394E-09,9.649E-08
GO:0004252,serine-type endopeptidase activity,Q2KJ63(Evidence code:IEA/Database source:InterPro:IPR001254|I)F1N1S6(Evidence code:IEA/Database source:InterPro:IPR001254|I)P00743(Evidence code:IEA/Database source:InterPro:IPR001254|I)A8E4N2(Evidence code:IEA/Database source:InterPro:IPR001254)Q0V8B6(Evidence code:IEA/Database source:InterPro:IPR036852)I2E4T6(Evidence code:IEA/Database source:InterPro:IPR037571)Q28193(Evidence code:IEA/Database source:InterPro:IPR000209|I)P98140(Evidence code:IEA/Database source:InterPro:IPR001254|I), KLKB1 C1RL F10 MASP1 TPP1 MASP2 FURIN F12,MF,8,8 of 57,4.62,14.04,3.016E-09,1.165E-07
GO:0038191,neuropilin binding,A5D7C8(Evidence code:IBA/Database source:PANTHER:PTN000112375)A7MB70(Evidence code:IBA/Database source:PANTHER:PTN000867406)Q5EA85(Evidence code:IBA/Database source:PANTHER:PTN000709529)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens), SEMA4D SEMA3C SEMA4A SEMA3A,MF,4,4 of 1,2.31,400,4.24E-09,1.572E-07
GO:0046872,metal ion binding,Q0VD27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2HJD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q17QK3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P56965(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2T9S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2KJ64(Evidence code:IEA/Database source:InterPro:IPR006035|I)Q3MHX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)O62829(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7MBC0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A3KLR9(Evidence code:IEA/Database source:InterPro:IPR001424|I)Q9TTK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)O62830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BBX5(Evidence code:IEA/Database source:InterPro:IPR002888|I)Q58DK5(Evidence code:IEA/Database source:InterPro:IPR001731)Q0V8B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BIY5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P46446(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q5EA01(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR001604|I)Q8MJ24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479), ENOPH1 LMAN2L CPQ DDAH1 ERAP2 PGP COLEC12 ARG1 SUOX PPM1A AMDHD2 MMP2 ECSOD AOC3 PPM1B GALNT1 AOX2 ALAD TPP1 SULF2 ASPA ANG2 B4GAT1  FURIN ENPP2 LOXL4,MF,26,26 of 1125,15.03,2.31,5.479E-09,1.953E-07
GO:0005198,structural molecule activity,A6QQQ9(Evidence code:IEA/Database source:InterPro:IPR001664|I)Q148H8(Evidence code:IEA/Database source:InterPro:IPR001664)A6QP32(Evidence code:IEA/Database source:InterPro:IPR001664)Q2KI75(Evidence code:IEA/Database source:InterPro:IPR001664|I)A7YWM2(Evidence code:IEA/Database source:InterPro:IPR001664|I)A5PJJ1(Evidence code:IEA/Database source:InterPro:IPR001664|I)A1A4M3(Evidence code:IEA/Database source:InterPro:IPR001664)Q148J0(Evidence code:IEA/Database source:InterPro:IPR001664|I)F1MXG6(Evidence code:IEA/Database source:InterPro:IPR001664|I)G3X7V4(Evidence code:IEA/Database source:InterPro:IPR001664)A4FUZ0(Evidence code:IEA/Database source:InterPro:IPR001664)F1MSQ6(Evidence code:IEA/Database source:UniRule:UR000645361)A3KMY1(Evidence code:IEA/Database source:InterPro:IPR001664), KRT20 KRT72 KRT85 KRT222 KRT40 KRT33A KRT86 KRT34 LOC618455 LOC787600 KRT83 NEFH KRT82,MF,13,13 of 294,7.51,4.42,2.588E-08,8.884E-07
GO:0071526,semaphorin-plexin signaling pathway,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens)A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens)Q769I5(Evidence code:ISS/Database source:UniProtKB:P08581)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens), SEMA3C SEMA4D MET SEMA3A,BP,4,4 of 3,2.31,133.33,2.942E-08,9.741E-07
GO:0005887,integral component of plasma membrane,Q08DN1(Evidence code:IEA/Database source:UniProtKB:O75509|ens)E1BD40(Evidence code:IBA/Database source:PANTHER:PTN001932250)A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens)A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)Q2TBL2(Evidence code:IBA/Database source:PANTHER:PTN000589024)P49259(Evidence code:IBA/Database source:PANTHER:PTN000177070)F1N780(Evidence code:IEA/Database source:InterPro:IPR016257)A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens)F1MNL4(Evidence code:IEA/Database source:InterPro:IPR033024)E1BJP8(Evidence code:IBA/Database source:PANTHER:PTN001932250)F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens), TNFRSF21 PCDHGB2 SEMA4D TNFRSF6B CADM1 PLA2R1 EPHA7 LMAN2 NEO1 PCDHGA7 RET,CC,11,11 of 209,6.36,5.26,5.433E-08,0.000001737
GO:0030145,manganese ion binding,O62829(Evidence code:IEA/Database source:InterPro:IPR012911|I)F1N283(Evidence code:IEA/Database source:UniProtKB:Q3U4G3|ens)O62830(Evidence code:IEA/Database source:InterPro:IPR012911|I)Q07537(Evidence code:IEA/Database source:UniProtKB:Q10472|ens)E1BBP1(Evidence code:IEA/Database source:UniProtKB:Q14435|ens), PPM1A XXYLT1 PPM1B GALNT1 GALNT3,MF,5,5 of 15,2.89,33.33,6.753E-08,0.000002087
GO:0010469,regulation of signaling receptor activity,P19879(Evidence code:IEA/Database source:GO:0008083)Q3SWW8(Evidence code:IEA/Database source:GO:0008083)P22444(Evidence code:IEA/Database source:GO:0005125)A6QL48(Evidence code:IEA/Database source:GO:0005125)G3X6G7(Evidence code:IEA/Database source:GO:0005179), OGN THBS4 BMP3 IL34 METRNL,BP,5,5 of 22,2.89,22.73,3.405E-07,0.00001018
GO:0008233,peptidase activity,Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q0V8B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q17QK3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P98140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q95M12(Evidence code:IEA/Database source:InterPro:IPR001096)P00743(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P25975(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645), KLKB1 ERAP2 TPP1 CPQ F12 LGMN F10 MMP2 CTSL FURIN,MF,10,10 of 205,5.78,4.88,4.119E-07,0.00001193
GO:0007411,axon guidance,Q5EA01(Evidence code:IEA/Database source:UniProtKB:Q8BWP8|ens)A7MB70(Evidence code:ISS/Database source:UniProtKB:Q62181)F1MNL4(Evidence code:IEA/Database source:InterPro:IPR033024)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens), B4GAT1  SEMA3C NEO1 CNTN2 SEMA3A,BP,5,5 of 24,2.89,20.83,4.963E-07,0.00001394
GO:0030215,semaphorin receptor binding,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens)A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens)A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens), SEMA3A SEMA3C SEMA4D,MF,3,3 of 1,1.73,300,6.228E-07,0.00001698
GO:0030424,axon,F1MEW1(Evidence code:IBA/Database source:PANTHER:PTN000112586)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens)F1MME1(Evidence code:IEA/Database source:UniProtKB:P35822|ens)Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens), SEMA3A CNTN2 PTPRK TNFRSF21 PPT1 NEFH,CC,6,6 of 56,3.47,10.71,0.000001212,0.0000321
GO:0005520,insulin-like growth factor binding,F1MW38(Evidence code:IEA/Database source:InterPro:IPR000867)A5D7V3(Evidence code:IEA/Database source:InterPro:IPR000867)Q05717(Evidence code:IEA/Database source:InterPro:IPR000867|I)O18739(Evidence code:IEA/Database source:InterPro:IPR000867), CRIM1 ESM1 IGFBP5 CTGF,MF,4,4 of 12,2.31,33.33,0.000001471,0.00003787
GO:0004653,polypeptide N-acetylgalactosaminyltransferase activity,E1BKQ9(Evidence code:IEA/Database source:UniProtKB:Q7Z7M9|ens)Q07537(Evidence code:IEA/Database source:EC:2.4.1.41)E1BBP1(Evidence code:IEA/Database source:UniProtKB:Q14435|ens), GALNT5 GALNT1 GALNT3,MF,3,3 of 2,1.73,150,0.000001551,0.00003885
GO:0005975,carbohydrate metabolic process,Q29444(Evidence code:IEA/Database source:InterPro:IPR006103)Q9MYM4(Evidence code:IEA/Database source:InterPro:IPR000322|I)Q2T9S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)A7MBC0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)Q1JPE3(Evidence code:IEA/Database source:InterPro:IPR018484)Q95M17(Evidence code:IEA/Database source:InterPro:IPR001223|I)G3MY87(Evidence code:IEA/Database source:InterPro:IPR000322|I)E1BDR2(Evidence code:IEA/Database source:InterPro:IPR000514), MANBA GAA PGP AMDHD2 CARKL CHIA MGAM IDUA,BP,8,8 of 144,4.62,5.56,0.000002277,0.00005554
GO:0006486,protein glycosylation,Q5EA01(Evidence code:IEA/Database source:UniPathway:UPA00378)E1BPW0(Evidence code:IEA/Database source:UniPathway:UPA00378)Q07537(Evidence code:IEA/Database source:UniPathway:UPA00378)E1BKQ9(Evidence code:IEA/Database source:UniPathway:UPA00378)E1BBP1(Evidence code:IEA/Database source:UniPathway:UPA00378)Q6ZXD2(Evidence code:IEA/Database source:InterPro:IPR001675|I), B4GAT1  ENTPD5 GALNT1 GALNT5 GALNT3 ST8SIA1,BP,6,6 of 66,3.47,9.09,0.000002938,0.00006983
GO:0005518,collagen binding,F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens)Q05443(Evidence code:IEA/Database source:UniProtKB:P51884|ens)P21793(Evidence code:IEA/Database source:InterPro:IPR028549)Q3SYW7(Evidence code:IEA/Database source:InterPro:IPR037641), LRRC15 LUM DCN SPARCL1,MF,4,4 of 15,2.31,26.67,0.000003091,0.00007164
GO:0004553,"hydrolase activity, hydrolyzing O-glycosyl compounds",E1BDR2(Evidence code:IEA/Database source:InterPro:IPR000514)G3MY87(Evidence code:IEA/Database source:InterPro:IPR000322)Q95M17(Evidence code:IEA/Database source:InterPro:IPR001579)Q29444(Evidence code:IEA/Database source:InterPro:IPR006103)Q9MYM4(Evidence code:IEA/Database source:InterPro:IPR000322), IDUA MGAM CHIA MANBA GAA,MF,5,5 of 38,2.89,13.16,0.000003773,0.00008491
GO:0005044,scavenger receptor activity,G3MYM8(Evidence code:IEA/Database source:InterPro:IPR001212|I)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR001212|I)Q8MJ24(Evidence code:IEA/Database source:InterPro:IPR001190)Q32L50(Evidence code:IEA/Database source:InterPro:IPR001212|I), PRG4 ENPP2 LOXL4 SBSPON,MF,4,4 of 16,2.31,25,0.000003847,0.00008491
GO:0016740,transferase activity,P00570(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1N283(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MS00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BBP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q9XSC6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5PJH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2KIW4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1N780(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BKQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q769I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q95KW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q29RN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q5EA01(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808), AK1 GALNT1 ST8SIA1 XXYLT1 RET GALNT3 CKM UPP1 LCAT EPHA7 GALNT5 MET ART3 GYG1 B4GAT1 ,MF,15,15 of 633,8.67,2.37,0.000004954,0.0001068
GO:0055114,oxidation-reduction process,A3KLR9(Evidence code:IEA/Database source:InterPro:IPR018152)Q8MJ24(Evidence code:IEA/Database source:InterPro:IPR001695|I)E1BBX5(Evidence code:IEA/Database source:InterPro:IPR002346|I)Q3MHX0(Evidence code:IEA/Database source:InterPro:IPR005066|I)Q9TTK6(Evidence code:IEA/Database source:InterPro:IPR000269|I)E1BKZ1(Evidence code:IEA/Database source:InterPro:IPR004099|I)F1MW08(Evidence code:IEA/Database source:InterPro:IPR007266|I)A5PJN2(Evidence code:IEA/Database source:InterPro:IPR007266|I), ECSOD LOXL4 AOX2 SUOX AOC3 GSR ERO1B ERO1A ,BP,8,8 of 162,4.62,4.94,0.000005206,0.0001085
GO:0004721,phosphoprotein phosphatase activity,F1MME1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)F1MFJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)O62829(Evidence code:IEA/Database source:InterPro:IPR012911|I)O62830(Evidence code:IEA/Database source:InterPro:IPR012911|I)Q2T9S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904), PTPRK PTPRG PPM1A PPM1B PGP,MF,5,5 of 41,2.89,12.2,0.0000053,0.0001085
GO:0035335,peptidyl-tyrosine dephosphorylation,Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8)F1MFJ3(Evidence code:IEA/Database source:GO:0004725)F1MME1(Evidence code:IEA/Database source:GO:0004725), PGP PTPRG PTPRK,BP,3,3 of 4,1.73,75,0.000005383,0.0001085
GO:0030247,polysaccharide binding,A1A4K5(Evidence code:IEA/Database source:InterPro:IPR001212|I)Q32L50(Evidence code:IEA/Database source:InterPro:IPR001212|I)G3MYM8(Evidence code:IEA/Database source:InterPro:IPR001212|I), ENPP2 SBSPON PRG4,MF,3,3 of 5,1.73,60,0.000008577,0.0001692
GO:0006470,protein dephosphorylation,F1MME1(Evidence code:IEA/Database source:InterPro:IPR000242)O62830(Evidence code:IEA/Database source:InterPro:IPR015655)F1MFJ3(Evidence code:IEA/Database source:InterPro:IPR000242)O62829(Evidence code:IEA/Database source:InterPro:IPR015655), PTPRK PPM1B PTPRG PPM1A,BP,4,4 of 24,2.31,16.67,0.0000157,0.0003032
GO:0031012,extracellular matrix,P21793(Evidence code:IDA/Database source:)E1BI98(Evidence code:IEA/Database source:UniProtKB:Q04857|ens)F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens)Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2)Q05443(Evidence code:ISS/Database source:UniProtKB:P51885)Q9GLE5(Evidence code:IEA/Database source:InterPro:IPR001818|I)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens), DCN COL6A1 LRRC15 THBS4 LUM MMP2 CTGF,CC,7,7 of 137,4.05,5.11,0.0000161,0.0003046
GO:0007275,multicellular organism development,P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A7MB70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A5PKI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)O19116(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217), ANG2 BMP3 SEMA3C FAM3C TNFRSF6B SEMA4A SFRP1,BP,7,7 of 145,4.05,4.83,0.0000228,0.0004227
GO:0000287,magnesium ion binding,O62829(Evidence code:IEA/Database source:InterPro:IPR012911|I)Q0VD27(Evidence code:IEA/Database source:InterPro:IPR023943)O62830(Evidence code:IEA/Database source:InterPro:IPR012911|I)F1N283(Evidence code:IEA/Database source:UniProtKB:Q8NBI6|ens)Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8), PPM1A ENOPH1 PPM1B XXYLT1 PGP,MF,5,5 of 58,2.89,8.62,0.00002515,0.0004571
GO:0005737,cytoplasm,Q95M17(Evidence code:ISS/Database source:UniProtKB:Q91XA9)Q0VC68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens)P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens)Q9XSC6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q5BIR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2KJ64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P12036|ens)A3KLR9(Evidence code:IBA/Database source:PANTHER:PTN000000113)E1BE60(Evidence code:IEA/Database source:InterPro:IPR008025|I)A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000164249)P46446(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q9Y646)Q27965(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A5PJH9(Evidence code:IEA/Database source:InterPro:IPR010059)P21793(Evidence code:IBA/Database source:PANTHER:PTN000043893)Q0VD27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MMI6(Evidence code:IBA/Database source:PANTHER:PTN000043893)O62830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P00570(Evidence code:IEA/Database source:InterPro:IPR006267)O62829(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963), CHIA SEPT5 CARKL PRKAR1A CKM SERPINB8 ARG1 NEFH ECSOD PPP1R14A ERAP2 ASPA CPQ HSPA1B UPP1 DCN ENOPH1 LRRC15 PPM1B AK1 PPM1A,CC,21,21 of 1304,12.14,1.61,0.00002724,0.0004856
GO:0010466,negative regulation of peptidase activity,A2VE29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)P56652(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)Q5BIR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)Q3ZBZ6(Evidence code:IEA/Database source:GO:0060422), ITIH5 ITIH3 SERPINB8 GPC3,BP,4,4 of 32,2.31,12.5,0.00004361,0.0007487
GO:0018108,peptidyl-tyrosine phosphorylation,F1MS00(Evidence code:IEA/Database source:GO:0004713)F1N780(Evidence code:IEA/Database source:GO:0004713)Q769I5(Evidence code:IEA/Database source:GO:0004713), RET EPHA7 MET,BP,3,3 of 10,1.73,30,0.00004292,0.0007487
GO:0008236,serine-type peptidase activity,P98140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)Q0V8B6(Evidence code:IEA/Database source:InterPro:IPR015366)Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)P00743(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720), F12 TPP1 KLKB1 FURIN F10,MF,5,5 of 67,2.89,7.46,0.00004805,0.0008098
GO:0001525,angiogenesis,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0037)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0037)A5D7V3(Evidence code:IEA/Database source:UniProtKB:Q9NQ30|ens)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0037), CTGF ANG2 SEMA4A ESM1 MMP2,BP,5,5 of 71,2.89,7.04,0.0000623,0.001031
GO:0043171,peptide catabolic process,A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000164249)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q9Y646)Q0V8B6(Evidence code:ISS/Database source:UniProtKB:O14773), ERAP2 CPQ TPP1,BP,3,3 of 12,1.73,25,0.00006773,0.001101
GO:0006954,inflammatory response,Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0395)Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0395)F1MYJ3(Evidence code:IEA/Database source:UniProtKB:Q9Z2A9|ens)A6QL48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0395)Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849)A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849), KLKB1 CHIA GGT5 IL34 TNFRSF21 TNFRSF6B,BP,6,6 of 121,3.47,4.96,0.00007505,0.001179
GO:0001558,regulation of cell growth,Q05717(Evidence code:IEA/Database source:InterPro:IPR000867)F1MW38(Evidence code:IEA/Database source:InterPro:IPR000867)O18739(Evidence code:IEA/Database source:InterPro:IPR000867)F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens)A5D7V3(Evidence code:IEA/Database source:InterPro:IPR000867), IGFBP5 CRIM1 CTGF CLSTN1 ESM1,BP,5,5 of 74,2.89,6.76,0.00007497,0.001179
GO:0004558,"alpha-1,4-glucosidase activity",Q9MYM4(Evidence code:IEA/Database source:EC:3.2.1.20)G3MY87(Evidence code:IEA/Database source:UniProtKB:B5THE2|ens), GAA MGAM,MF,2,2 of 1,1.16,200,0.00008626,0.001211
GO:0043569,negative regulation of insulin-like growth factor receptor signaling pathway,Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens)E1BIR5(Evidence code:IEA/Database source:UniProtKB:O75339|ens), IGFBP5 CILP,BP,2,2 of 1,1.16,200,0.00008626,0.001211
GO:0060666,dichotomous subdivision of terminal units involved in salivary gland branching,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens)A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens), SEMA3A SEMA3C,BP,2,2 of 1,1.16,200,0.00008626,0.001211
GO:0043931,ossification involved in bone maturation,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens)A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens), DCHS1 SEMA4D,BP,2,2 of 1,1.16,200,0.00008626,0.001211
GO:0018243,protein O-linked glycosylation via threonine,Q07537(Evidence code:IEA/Database source:UniProtKB:Q10472|ens)E1BBP1(Evidence code:IEA/Database source:UniProtKB:Q14435|ens), GALNT1 GALNT3,BP,2,2 of 1,1.16,200,0.00008626,0.001211
GO:0045499,chemorepellent activity,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens), EPHA7 SEMA3A,MF,2,2 of 1,1.16,200,0.00008626,0.001211
GO:1901223,negative regulation of NIK/NF-kappaB signaling,O62830(Evidence code:ISS/Database source:UniProtKB:O75688)O62829(Evidence code:ISS/Database source:UniProtKB:P35813), PPM1B PPM1A,BP,2,2 of 1,1.16,200,0.00008626,0.001211
GO:0016311,dephosphorylation,F1MME1(Evidence code:IEA/Database source:InterPro:IPR000387|I)F1MFJ3(Evidence code:IEA/Database source:InterPro:IPR000387|I)Q0VD27(Evidence code:IEA/Database source:GO:0043874)Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8), PTPRK PTPRG ENOPH1 PGP,BP,4,4 of 39,2.31,10.26,0.00008863,0.001226
GO:0004713,protein tyrosine kinase activity,F1MS00(Evidence code:IEA/Database source:InterPro:IPR020635)F1N780(Evidence code:IEA/Database source:InterPro:IPR020635)Q769I5(Evidence code:IEA/Database source:InterPro:IPR020635), RET EPHA7 MET,MF,3,3 of 14,1.73,21.43,0.0001004,0.001369
GO:0005178,integrin binding,Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens)A5D7V3(Evidence code:IEA/Database source:UniProtKB:Q9NQ30|ens), THBS4 CTGF ESM1,MF,3,3 of 17,1.73,17.65,0.0001663,0.002213
GO:0046007,negative regulation of activated T cell proliferation,Q2KJ64(Evidence code:IEA/Database source:UniProtKB:Q61176|ens)P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens), ARG1 PRKAR1A,BP,2,2 of 2,1.16,100,0.0001719,0.002213
GO:0007413,axonal fasciculation,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens), SEMA3A CNTN2,BP,2,2 of 2,1.16,100,0.0001719,0.002213
GO:0018242,protein O-linked glycosylation via serine,E1BBP1(Evidence code:IEA/Database source:UniProtKB:Q14435|ens)Q07537(Evidence code:IEA/Database source:UniProtKB:Q10472|ens), GALNT3 GALNT1,BP,2,2 of 2,1.16,100,0.0001719,0.002213
GO:0016798,"hydrolase activity, acting on glycosyl bonds",Q29444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q9MYY0(Evidence code:IEA/Database source:InterPro:IPR005199)Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q9MYM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326), MANBA HPSE CHIA GAA,MF,4,4 of 48,2.31,8.33,0.000187,0.002374
GO:0004725,protein tyrosine phosphatase activity,F1MFJ3(Evidence code:IEA/Database source:InterPro:IPR000242|I)Q2T9S4(Evidence code:IEA/Database source:EC:3.1.3.48)F1MME1(Evidence code:IEA/Database source:InterPro:IPR000242|I), PTPRG PGP PTPRK,MF,3,3 of 18,1.73,16.67,0.0001932,0.00242
GO:0000139,Golgi membrane,Q2HJD1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VC16(Evidence code:IEA/Database source:GO:0090110)E1BKQ9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5EA01(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BBP1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), LMAN2L ST8SIA1 MIA3 GALNT5 B4GAT1  GALNT3,CC,6,6 of 147,3.47,4.08,0.0002074,0.002564
GO:0005622,intracellular,F1MJV6(Evidence code:IEA/Database source:GO:0007189)E1B969(Evidence code:IEA/Database source:GO:0035329)P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens)E1BEC6(Evidence code:IEA/Database source:GO:0007189)Q9MYY0(Evidence code:IBA/Database source:PANTHER:PTN001024080), ADGRG6 DCHS1 LDLR ADGRF1 HPSE,CC,5,5 of 95,2.89,5.26,0.0002277,0.002777
GO:0006955,immune response,A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)P17453(Evidence code:IEA/Database source:InterPro:IPR030181)Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849)A6QP79(Evidence code:IEA/Database source:UniProtKB:Q8K4Q8|ens)Q32L50(Evidence code:IEA/Database source:InterPro:IPR001212|I)G3MYM8(Evidence code:IEA/Database source:InterPro:IPR001212|I)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR001212|I), TNFRSF6B BPI TNFRSF21 COLEC12 SBSPON PRG4 ENPP2,BP,7,7 of 214,4.05,3.27,0.0002352,0.002832
GO:0001822,kidney development,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens)E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens), DCHS1 SULF2 GPC3,BP,3,3 of 20,1.73,15,0.0002552,0.003032
GO:0022417,protein maturation by protein folding,A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens)F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens), ERO1A  ERO1B,BP,2,2 of 3,1.16,66.67,0.0002854,0.003188
GO:0010839,negative regulation of keratinocyte proliferation,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens), CTSL PTPRK,BP,2,2 of 3,1.16,66.67,0.0002854,0.003188
GO:0007042,lysosomal lumen acidification,Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)P45478(Evidence code:ISS/Database source:UniProtKB:P50897), CLN5 PPT1,BP,2,2 of 3,1.16,66.67,0.0002854,0.003188
GO:0030169,low-density lipoprotein particle binding,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens)A6QP79(Evidence code:ISS/Database source:UniProtKB:Q5KU26), LDLR COLEC12,MF,2,2 of 3,1.16,66.67,0.0002854,0.003188
GO:0008484,sulfuric ester hydrolase activity,E1BIY5(Evidence code:IEA/Database source:InterPro:IPR000917|I)F1N2D5(Evidence code:IEA/Database source:InterPro:IPR000917), SULF2 IDS,MF,2,2 of 3,1.16,66.67,0.0002854,0.003188
GO:0051897,positive regulation of protein kinase B signaling,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens)F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens)P00743(Evidence code:IEA/Database source:UniProtKB:P00742|ens), IGFBP5 RET F10,BP,3,3 of 21,1.73,14.29,0.0002904,0.003205
GO:0016310,phosphorylation,Q9XSC6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P00570(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q1JPE3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MS00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1N780(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q769I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418), CKM AK1 CARKL RET EPHA7 MET,BP,6,6 of 164,3.47,3.66,0.0003642,0.003972
GO:0008083,growth factor activity,P19879(Evidence code:IEA/Database source:UniProtKB-KW:KW-0339)Q3SWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0339)A6QL48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0339)P22444(Evidence code:IEA/Database source:InterPro:IPR001839|I), OGN THBS4 IL34 BMP3,MF,4,4 of 60,2.31,6.67,0.0004165,0.004299
GO:0030513,positive regulation of BMP signaling pathway,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)F1MNL4(Evidence code:IEA/Database source:InterPro:IPR033024), GPC3 NEO1,BP,2,2 of 4,1.16,50,0.0004266,0.004299
GO:0001968,fibronectin binding,F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), LRRC15 IGFBP5,MF,2,2 of 4,1.16,50,0.0004266,0.004299
GO:0005031,tumor necrosis factor-activated receptor activity,A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849), TNFRSF6B TNFRSF21,MF,2,2 of 4,1.16,50,0.0004266,0.004299
GO:0019471,4-hydroxyproline metabolic process,F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens)A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens), ERO1B ERO1A ,BP,2,2 of 4,1.16,50,0.0004266,0.004299
GO:0006499,N-terminal protein myristoylation,O62829(Evidence code:ISS/Database source:UniProtKB:P49443)O62830(Evidence code:ISS/Database source:UniProtKB:P36993), PPM1A PPM1B,BP,2,2 of 4,1.16,50,0.0004266,0.004299
GO:0045721,negative regulation of gluconeogenesis,A5PKI3(Evidence code:IEA/Database source:InterPro:IPR039219)Q2T9S4(Evidence code:ISS/Database source:UniProtKB:A6NDG6), FAM3C PGP,BP,2,2 of 4,1.16,50,0.0004266,0.004299
GO:0005829,cytosol,F1ME65(Evidence code:IEA/Database source:UniProtKB:A0A024RBH2)Q5BIR5(Evidence code:IEA/Database source:UniProtKB:P50452|ens)P45478(Evidence code:IDA/Database source:)Q58DK5(Evidence code:IBA/Database source:PANTHER:PTN000156046)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens)O62829(Evidence code:ISS/Database source:UniProtKB:P49443)Q1ZYR0(Evidence code:IEA/Database source:GO:0042147)Q2T9S4(Evidence code:IBA/Database source:PANTHER:PTN000445812)E1BBX5(Evidence code:IBA/Database source:PANTHER:PTN000225632)F1MS00(Evidence code:IEA/Database source:UniProtKB:A0A024R7T2)P00570(Evidence code:IEA/Database source:UniProtKB:Q5T9B7|ens)O62830(Evidence code:ISS/Database source:UniProtKB:P36993)F1N2J8(Evidence code:IEA/Database source:UniProtKB:Q6UX73|ens), CKAP4 SERPINB8 PPT1 ALAD SORT1 PPM1A CLN5 PGP AOX2 RET AK1 PPM1B C16orf89,CC,13,13 of 769,7.51,1.69,0.0004899,0.004855
GO:0016301,kinase activity,Q769I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q1JPE3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P00570(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MS00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q9XSC6(Evidence code:IEA/Database source:InterPro:IPR022413|I)F1N780(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418), MET CARKL AK1 RET CKM EPHA7,MF,6,6 of 174,3.47,3.45,0.0004923,0.004855
GO:0005789,endoplasmic reticulum membrane,A6QPT7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MW08(Evidence code:IBA/Database source:PANTHER:PTN000289179)Q0VC23(Evidence code:IEA/Database source:InterPro:IPR029801)Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6)A5PJN2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2HJD1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T083(Evidence code:IBA/Database source:PANTHER:PTN000006098), ERAP2 ERO1B ATF6 MIA3 ERO1A  LMAN2L SDF2L1,CC,7,7 of 244,4.05,2.87,0.0005028,0.004906
GO:0016671,"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor",F1MW08(Evidence code:IEA/Database source:InterPro:IPR007266|I)A5PJN2(Evidence code:IEA/Database source:InterPro:IPR007266|I), ERO1B ERO1A ,MF,2,2 of 5,1.16,40,0.0005951,0.005409
GO:0043236,laminin binding,F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q6F3F9|ens)F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens), ADGRG6 LRRC15,MF,2,2 of 5,1.16,40,0.0005951,0.005409
GO:0042130,negative regulation of T cell proliferation,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens)Q2KJ64(Evidence code:IEA/Database source:UniProtKB:P05089|ens), TNFRSF21 ARG1,BP,2,2 of 5,1.16,40,0.0005951,0.005409
GO:0003007,heart morphogenesis,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens)E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens), GAA DCHS1,BP,2,2 of 5,1.16,40,0.0005951,0.005409
GO:0004714,transmembrane receptor protein tyrosine kinase activity,Q769I5(Evidence code:IEA/Database source:InterPro:IPR016244)F1MS00(Evidence code:IEA/Database source:EC:2.7.10.1), MET RET,MF,2,2 of 5,1.16,40,0.0005951,0.005409
GO:0034975,protein folding in endoplasmic reticulum,A5PJN2(Evidence code:IBA/Database source:PANTHER:PTN000289179)F1MW08(Evidence code:IBA/Database source:PANTHER:PTN000289179), ERO1A  ERO1B,BP,2,2 of 5,1.16,40,0.0005951,0.005409
GO:0021915,neural tube development,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens)E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens), SEMA3C DCHS1,BP,2,2 of 5,1.16,40,0.0005951,0.005409
GO:0007420,brain development,P45478(Evidence code:ISS/Database source:UniProtKB:P50897)Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens), PPT1 CLN5 EPHA7,BP,3,3 of 28,1.73,10.71,0.0006269,0.005642
GO:0045454,cell redox homeostasis,A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens)F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens)E1BKZ1(Evidence code:IEA/Database source:InterPro:IPR004099), ERO1A  ERO1B GSR,BP,3,3 of 30,1.73,10,0.0007548,0.006663
GO:0005507,copper ion binding,A3KLR9(Evidence code:IBA/Database source:PANTHER:PTN000000113)Q9TTK6(Evidence code:IEA/Database source:InterPro:IPR000269|I)Q8MJ24(Evidence code:IEA/Database source:InterPro:IPR001695|I), ECSOD AOC3 LOXL4,MF,3,3 of 30,1.73,10,0.0007548,0.006663
GO:0035269,protein O-linked mannosylation,Q5EA01(Evidence code:ISS/Database source:UniProtKB:O43505)Q3T083(Evidence code:IEA/Database source:GO:0004169), B4GAT1  SDF2L1,BP,2,2 of 6,1.16,33.33,0.0007906,0.006786
GO:0001755,neural crest cell migration,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens)F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens), SEMA3C RET,BP,2,2 of 6,1.16,33.33,0.0007906,0.006786
GO:0033209,tumor necrosis factor-mediated signaling pathway,Q08DN1(Evidence code:IEA/Database source:GO:0005031)A6QPW7(Evidence code:IEA/Database source:GO:0005031), TNFRSF21 TNFRSF6B,BP,2,2 of 6,1.16,33.33,0.0007906,0.006786
GO:0004197,cysteine-type endopeptidase activity,Q95M12(Evidence code:ISS/Database source:UniProtKB:O89017)Q0VCU3(Evidence code:IBA/Database source:PANTHER:PTN000274640)P25975(Evidence code:IBA/Database source:PANTHER:PTN000274640), LGMN CTSF CTSL,MF,3,3 of 31,1.73,9.68,0.0008245,0.006948
GO:0007596,blood coagulation,P00743(Evidence code:IEA/Database source:InterPro:IPR012224)Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0094)P98140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0094), F10 KLKB1 F12,BP,3,3 of 31,1.73,9.68,0.0008245,0.006948
GO:0007599,hemostasis,P00743(Evidence code:IEA/Database source:UniProtKB-KW:KW-0356)P98140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0356)Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0356), F10 F12 KLKB1,BP,3,3 of 32,1.73,9.38,0.0008981,0.0075
GO:0071353,cellular response to interleukin-4,Q58DK5(Evidence code:IEA/Database source:UniProtKB:P10518|ens)Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens), ALAD CARKL,BP,2,2 of 7,1.16,28.57,0.001013,0.008236
GO:0050885,neuromuscular process controlling balance,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens)E1BI28(Evidence code:IEA/Database source:UniProtKB:Q60648|ens), GAA GM2A,BP,2,2 of 7,1.16,28.57,0.001013,0.008236
GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens)Q2TBL2(Evidence code:IBA/Database source:PANTHER:PTN000589024), DCHS1 CADM1,BP,2,2 of 7,1.16,28.57,0.001013,0.008236
GO:0008270,zinc ion binding,Q9GLE5(Evidence code:IEA/Database source:InterPro:IPR001818|I)A3KLR9(Evidence code:IBA/Database source:PANTHER:PTN000000113)A1A4K5(Evidence code:ISS/Database source:UniProtKB:Q13822)P56965(Evidence code:IDA/Database source:)Q58DK5(Evidence code:ISS/Database source:UniProtKB:P13716)A6QPT7(Evidence code:IEA/Database source:InterPro:IPR014782), MMP2 ECSOD ENPP2 DDAH1 ALAD ERAP2,MF,6,6 of 207,3.47,2.9,0.001175,0.009473
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,A1A4K5(Evidence code:IEA/Database source:UniProtKB:Q13822|ens)Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens)A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens), ENPP2 THBS4 SEMA4D,BP,3,3 of 36,1.73,8.33,0.001234,0.009508
GO:0031069,hair follicle morphogenesis,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), CTSL IGFBP5,BP,2,2 of 8,1.16,25,0.001262,0.009508
GO:0030212,hyaluronan metabolic process,A2VE29(Evidence code:IEA/Database source:InterPro:IPR010600)P56652(Evidence code:IEA/Database source:InterPro:IPR010600), ITIH5 ITIH3,BP,2,2 of 8,1.16,25,0.001262,0.009508
GO:0022008,neurogenesis,Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens), CLN5 DCHS1,BP,2,2 of 8,1.16,25,0.001262,0.009508
GO:0045668,negative regulation of osteoblast differentiation,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens)A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens), IGFBP5 SEMA4D,BP,2,2 of 8,1.16,25,0.001262,0.009508
GO:0003756,protein disulfide isomerase activity,A5PJN2(Evidence code:IEA/Database source:InterPro:IPR007266|I)F1MW08(Evidence code:IEA/Database source:InterPro:IPR007266|I), ERO1A  ERO1B,MF,2,2 of 8,1.16,25,0.001262,0.009508
GO:0001658,branching involved in ureteric bud morphogenesis,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens), GPC3 DCHS1,BP,2,2 of 8,1.16,25,0.001262,0.009508
GO:0046658,anchored component of plasma membrane,Q3ZBZ6(Evidence code:IEA/Database source:InterPro:IPR001863)E1BG25(Evidence code:IEA/Database source:UniProtKB:P08582|ens), GPC3 MELTF,CC,2,2 of 8,1.16,25,0.001262,0.009508
GO:0007267,cell-cell signaling,O18739(Evidence code:IBA/Database source:PANTHER:PTN000142748)E1BJP8(Evidence code:IBA/Database source:PANTHER:PTN001932250)A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000164501)E1BD40(Evidence code:IBA/Database source:PANTHER:PTN001932250), CTGF PCDHGA7 ERAP2 PCDHGB2,BP,4,4 of 83,2.31,4.82,0.001321,0.009875
GO:0030198,extracellular matrix organization,A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens)F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens)A5D7S8(Evidence code:IEA/Database source:InterPro:IPR017048), ERO1A  ERO1B FBLN1,BP,3,3 of 39,1.73,7.69,0.001531,0.01113
GO:0009897,external side of plasma membrane,F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens)P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens)E1BKZ1(Evidence code:IEA/Database source:UniProtKB:P47791|ens), IL1R1 LDLR GSR,CC,3,3 of 39,1.73,7.69,0.001531,0.01113
GO:0005537,mannose binding,Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens), CLN5 LMAN2,MF,2,2 of 9,1.16,22.22,0.001536,0.01113
GO:0015035,protein disulfide oxidoreductase activity,F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens)A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens), ERO1B ERO1A ,MF,2,2 of 9,1.16,22.22,0.001536,0.01113
GO:0051216,cartilage development,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens)P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0891), SULF2 BMP3,BP,2,2 of 10,1.16,20,0.001837,0.0129
GO:0030968,endoplasmic reticulum unfolded protein response,Q0VC23(Evidence code:IEA/Database source:InterPro:IPR029801)A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens), ATF6 ERO1A ,BP,2,2 of 10,1.16,20,0.001837,0.0129
GO:0001540,amyloid-beta binding,F1MD95(Evidence code:IEA/Database source:UniProtKB:O94985|ens)P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens), CLSTN1 LDLR,MF,2,2 of 10,1.16,20,0.001837,0.0129
GO:0042730,fibrinolysis,P98140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0280)Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0280), F12 KLKB1,BP,2,2 of 10,1.16,20,0.001837,0.0129
GO:0007040,lysosome organization,Q1ZYR0(Evidence code:IEA/Database source:UniProtKB:Q3UMW8|ens)Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P10253|ens), CLN5 GAA,BP,2,2 of 11,1.16,18.18,0.002163,0.01474
GO:0050873,brown fat cell differentiation,G3X6G7(Evidence code:IEA/Database source:UniProtKB:Q8VE43|ens)A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens), METRNL ERO1A ,BP,2,2 of 11,1.16,18.18,0.002163,0.01474
GO:0030324,lung development,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens), GPC3 CTGF,BP,2,2 of 11,1.16,18.18,0.002163,0.01474
GO:0005791,rough endoplasmic reticulum,F1ME65(Evidence code:IEA/Database source:UniProtKB:Q07065|ens)F1MS76(Evidence code:IEA/Database source:UniProtKB:Q8C341|ens), CKAP4 SUCO,CC,2,2 of 11,1.16,18.18,0.002163,0.01474
GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,O62830(Evidence code:ISS/Database source:UniProtKB:O75688)O62829(Evidence code:ISS/Database source:UniProtKB:P35813), PPM1B PPM1A,BP,2,2 of 12,1.16,16.67,0.002515,0.01665
GO:0051496,positive regulation of stress fiber assembly,O19116(Evidence code:IDA/Database source:)O18739(Evidence code:IEA/Database source:UniProtKB:P29279|ens), SFRP1 CTGF,BP,2,2 of 12,1.16,16.67,0.002515,0.01665
GO:0050840,extracellular matrix binding,Q3SYW7(Evidence code:IBA/Database source:PANTHER:PTN001015480)P21793(Evidence code:IEA/Database source:UniProtKB:P28654|ens), SPARCL1 DCN,MF,2,2 of 12,1.16,16.67,0.002515,0.01665
GO:0005913,cell-cell adherens junction,Q2TBL2(Evidence code:IBA/Database source:PANTHER:PTN000589024)A6QLR1(Evidence code:IEA/Database source:UniProtKB:Q96NY8|ens), CADM1 PVRL4,CC,2,2 of 12,1.16,16.67,0.002515,0.01665
GO:0005905,clathrin-coated pit,P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens), LDLR SORT1,CC,2,2 of 13,1.16,15.38,0.002891,0.01901
GO:0008237,metallopeptidase activity,Q17QK3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0482)A6QPT7(Evidence code:IEA/Database source:InterPro:IPR014782)Q9GLE5(Evidence code:IEA/Database source:InterPro:IPR006026|I), CPQ ERAP2 MMP2,MF,3,3 of 51,1.73,5.88,0.003152,0.02058
GO:0008201,heparin binding,Q28019(Evidence code:IEA/Database source:UniProtKB-KW:KW-0358)Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens)O18739(Evidence code:IEA/Database source:UniProtKB-KW:KW-0358), LTBP2 THBS4 CTGF,MF,3,3 of 52,1.73,5.77,0.00332,0.02066
GO:0006469,negative regulation of protein kinase activity,F1MMI6(Evidence code:IBA/Database source:PANTHER:PTN000043893)P21793(Evidence code:IBA/Database source:PANTHER:PTN000043893)P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens), LRRC15 DCN PRKAR1A,BP,3,3 of 52,1.73,5.77,0.00332,0.02066
GO:0002250,adaptive immune response,Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-1064)Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1064), SEMA4A TNFRSF21 ERAP2,BP,3,3 of 52,1.73,5.77,0.00332,0.02066
GO:0046426,negative regulation of JAK-STAT cascade,F1MMI6(Evidence code:IBA/Database source:PANTHER:PTN000043893)P21793(Evidence code:IBA/Database source:PANTHER:PTN000043893), LRRC15 DCN,BP,2,2 of 14,1.16,14.29,0.003292,0.02066
GO:0042552,myelination,F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q86SQ4|ens)Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens), ADGRG6 TNFRSF21,BP,2,2 of 14,1.16,14.29,0.003292,0.02066
GO:0007160,cell-matrix adhesion,A6QLI0(Evidence code:IEA/Database source:InterPro:IPR001299)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens), EPDR1 CTGF,BP,2,2 of 14,1.16,14.29,0.003292,0.02066
GO:0030301,cholesterol transport,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens)Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens), LDLR LCAT,BP,2,2 of 14,1.16,14.29,0.003292,0.02066
GO:0008234,cysteine-type peptidase activity,Q95M12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)P25975(Evidence code:IEA/Database source:InterPro:IPR000668|I)Q0VCU3(Evidence code:IEA/Database source:InterPro:IPR000668|I), LGMN CTSL CTSF,MF,3,3 of 53,1.73,5.66,0.003494,0.02159
GO:0004722,protein serine/threonine phosphatase activity,O62830(Evidence code:IEA/Database source:InterPro:IPR015655)O62829(Evidence code:IEA/Database source:InterPro:IPR015655), PPM1B PPM1A,MF,2,2 of 15,1.16,13.33,0.003718,0.02282
GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,F1N780(Evidence code:IEA/Database source:InterPro:IPR001426|I)Q769I5(Evidence code:IEA/Database source:InterPro:IPR016244)F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens), EPHA7 MET RET,BP,3,3 of 56,1.73,5.36,0.004049,0.02469
GO:0090263,positive regulation of canonical Wnt signaling pathway,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:P51654|ens), SULF2 GPC3,BP,2,2 of 16,1.16,12.5,0.004167,0.02509
GO:0032729,positive regulation of interferon-gamma production,A5D7S4(Evidence code:IEA/Database source:UniProtKB:O70394|ens)F1ML75(Evidence code:IEA/Database source:UniProtKB:P14778|ens), IL27RA IL1R1,BP,2,2 of 16,1.16,12.5,0.004167,0.02509
GO:0016491,oxidoreductase activity,Q8MJ24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)E1BBX5(Evidence code:IEA/Database source:InterPro:IPR002346|I)A5PJN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)A3KLR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)E1BKZ1(Evidence code:IEA/Database source:InterPro:IPR016156|I)Q3MHX0(Evidence code:IEA/Database source:InterPro:IPR005066|I)Q9TTK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560), LOXL4 AOX2 ERO1A  ECSOD GSR SUOX AOC3,MF,7,7 of 361,4.05,1.94,0.004331,0.0259
GO:0008285,negative regulation of cell proliferation,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)Q0P5D6(Evidence code:IEA/Database source:InterPro:IPR027261)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)P56965(Evidence code:IEA/Database source:UniProtKB:O94760|ens), GPC3 RARRES1 PTPRK DDAH1,BP,4,4 of 119,2.31,3.36,0.004615,0.02743
GO:0043235,receptor complex,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens)F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens)P49259(Evidence code:IEA/Database source:UniProtKB:Q13018|ens), LDLR RET PLA2R1,CC,3,3 of 61,1.73,4.92,0.005085,0.03003
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens)A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens), DCN SEMA4D,BP,2,2 of 18,1.16,11.11,0.005138,0.03015
GO:0045177,apical part of cell,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens)E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens), LDLR DCHS1,CC,2,2 of 19,1.16,10.53,0.005659,0.03258
GO:0042632,cholesterol homeostasis,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens)Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens), LDLR LCAT,BP,2,2 of 19,1.16,10.53,0.005659,0.03258
GO:0007409,axonogenesis,Q05443(Evidence code:IBA/Database source:PANTHER:PTN000689595)P19879(Evidence code:IBA/Database source:PANTHER:PTN000689992), LUM OGN,BP,2,2 of 19,1.16,10.53,0.005659,0.03258
GO:0098609,cell-cell adhesion,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens)Q9GKR2(Evidence code:IEA/Database source:InterPro:IPR003987|I)Q28161(Evidence code:IEA/Database source:InterPro:IPR028435), DCHS1 VCAM1 PKP1,BP,3,3 of 65,1.73,4.62,0.00602,0.03445
GO:0042803,protein homodimerization activity,Q2KJ63(Evidence code:IDA/Database source:)F1N2J8(Evidence code:IEA/Database source:UniProtKB:Q6UX73|ens)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q9Y646)P21793(Evidence code:IDA/Database source:)Q2TBL2(Evidence code:IBA/Database source:PANTHER:PTN000589024), KLKB1 C16orf89 CPQ DCN CADM1,MF,5,5 of 210,2.89,2.38,0.006596,0.03751
GO:0007189,adenylate cyclase-activating G-protein coupled receptor signaling pathway,E1BEC6(Evidence code:IEA/Database source:UniProtKB:Q8VEC3|ens)F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q6F3F9|ens), ADGRF1 ADGRG6,BP,2,2 of 21,1.16,9.52,0.006769,0.03826
GO:0006915,apoptotic process,Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q08DN1(Evidence code:IEA/Database source:UniProtKB:O75509|ens)A6QQQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)A5PJN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053), CHIA TNFRSF21 KRT20 ERO1A ,BP,4,4 of 151,2.31,2.65,0.01026,0.03899
GO:0016791,phosphatase activity,F1MME1(Evidence code:IEA/Database source:InterPro:IPR000387)Q2T9S4(Evidence code:IEA/Database source:InterPro:IPR006349)F1MFJ3(Evidence code:IEA/Database source:InterPro:IPR000387), PTPRK PGP PTPRG,MF,3,3 of 75,1.73,4,0.008779,0.03899
GO:0030414,peptidase inhibitor activity,Q5BIR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)P56652(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)A2VE29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646), SERPINB8 ITIH3 ITIH5,MF,3,3 of 80,1.73,3.75,0.01039,0.03899
GO:0045807,positive regulation of endocytosis,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens), LDLR GPC3,BP,2,2 of 25,1.16,8,0.009257,0.03899
GO:0016525,negative regulation of angiogenesis,Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens)P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens), THBS4 DCN,BP,2,2 of 24,1.16,8.33,0.008602,0.03899
GO:0042158,lipoprotein biosynthetic process,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P16301|ens),LCAT,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0000121,glycerol-1-phosphatase activity,Q2T9S4(Evidence code:IEA/Database source:EC:3.1.3.21),PGP,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0046709,IDP catabolic process,A7MBI8(Evidence code:IEA/Database source:UniProtKB:Q8BVU5|ens),NUDT9,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0035924,cellular response to vascular endothelial growth factor stimulus,G3MXM5(Evidence code:IEA/Database source:UniProtKB:P54826|ens),GAS1,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0032793,positive regulation of CREB transcription factor activity,E1BEC6(Evidence code:IEA/Database source:UniProtKB:Q8VEC3|ens),ADGRF1,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0034186,apolipoprotein A-I binding,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens),LCAT,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0017110,nucleoside-diphosphatase activity,E1BPW0(Evidence code:IEA/Database source:EC:3.6.1.6),ENTPD5,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:2001224,positive regulation of neuron migration,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0060384,innervation,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0003956,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,Q95KW3(Evidence code:IEA/Database source:InterPro:IPR000768),ART3,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0032596,protein transport into membrane raft,E1BKZ9(Evidence code:IMP/Database source:),SORT1,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0043874,acireductone synthase activity,Q0VD27(Evidence code:IEA/Database source:InterPro:IPR023943),ENOPH1,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0044224,juxtaparanode region of axon,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,CC,1,1 of 1,0.58,100,0.01068,0.03899
GO:0097252,oligodendrocyte apoptotic process,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0007158,neuron cell-cell adhesion,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:1902513,regulation of organelle transport along microtubule,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P12036|ens),NEFH,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0060336,negative regulation of interferon-gamma-mediated signaling pathway,Q2KJ64(Evidence code:IEA/Database source:UniProtKB:P05089|ens),ARG1,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0030305,heparanase activity,Q9MYY0(Evidence code:ISS/Database source:UniProtKB:Q9Y251),HPSE,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0005157,macrophage colony-stimulating factor receptor binding,A6QL48(Evidence code:IEA/Database source:InterPro:IPR020415),IL34,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0035963,cellular response to interleukin-13,Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens),CARKL,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0043136,glycerol-3-phosphatase activity,Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8),PGP,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0004567,beta-mannosidase activity,Q29444(Evidence code:IEA/Database source:EC:3.2.1.25),MANBA,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0010899,regulation of phosphatidylcholine catabolic process,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0044206,UMP salvage,A5PJH9(Evidence code:IEA/Database source:UniPathway:UPA00574),UPP1,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0045793,positive regulation of cell size,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0004655,porphobilinogen synthase activity,Q58DK5(Evidence code:IEA/Database source:InterPro:IPR001731),ALAD,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0060392,negative regulation of SMAD protein signal transduction,E1BIR5(Evidence code:IEA/Database source:UniProtKB:O75339|ens),CILP,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0097286,iron ion import,E1BG25(Evidence code:IEA/Database source:UniProtKB:P08582|ens),MELTF,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0009052,"pentose-phosphate shunt, non-oxidative branch",Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens),CARKL,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0031642,negative regulation of myelination,Q08DN1(Evidence code:IEA/Database source:UniProtKB:O75509|ens),TNFRSF21,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0017040,N-acylsphingosine amidohydrolase activity,Q17QB3(Evidence code:IEA/Database source:EC:3.5.1.23),ASAH1,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0035799,ureter maturation,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:1904426,positive regulation of GTP binding,Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503),CLN5,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:1904027,negative regulation of collagen fibril organization,P21793(Evidence code:IDA/Database source:),DCN,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0060168,positive regulation of adenosine receptor signaling pathway,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0098633,collagen fibril binding,P21793(Evidence code:IDA/Database source:),DCN,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0048936,peripheral nervous system neuron axonogenesis,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens),NEFH,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0030889,negative regulation of B cell proliferation,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0003273,cell migration involved in endocardial cushion formation,E1B969(Evidence code:IEA/Database source:UniProtKB:Q96JQ0|ens),DCHS1,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0045134,uridine-diphosphatase activity,E1BPW0(Evidence code:IEA/Database source:EC:3.6.1.6),ENTPD5,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0072138,mesenchymal cell proliferation involved in ureteric bud development,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0050436,microfibril binding,Q28019(Evidence code:IDA/Database source:),LTBP2,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0039706,co-receptor binding,F1MNL4(Evidence code:IEA/Database source:UniProtKB:Q92859|ens),NEO1,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:1904205,negative regulation of skeletal muscle hypertrophy,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0043181,vacuolar sequestering,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P10253|ens),GAA,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:2000394,positive regulation of lamellipodium morphogenesis,A1A4K5(Evidence code:IEA/Database source:UniProtKB:Q13822|ens),ENPP2,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0006172,ADP biosynthetic process,P00570(Evidence code:IEA/Database source:UniRule:UR000166136),AK1,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:1904707,positive regulation of vascular smooth muscle cell proliferation,Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens),IGFBP5,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0003350,pulmonary myocardium development,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0030299,intestinal cholesterol absorption,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens),LDLR,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0002086,diaphragm contraction,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P10253|ens),GAA,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0090599,alpha-glucosidase activity,Q9MYM4(Evidence code:IEA/Database source:EC:3.2.1.20),GAA,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0003183,mitral valve morphogenesis,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0005161,platelet-derived growth factor receptor binding,F1ML75(Evidence code:IEA/Database source:UniProtKB:P14778|ens),IL1R1,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0048846,axon extension involved in axon guidance,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0045880,positive regulation of smoothened signaling pathway,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0008967,phosphoglycolate phosphatase activity,Q2T9S4(Evidence code:ISS/Database source:UniProtKB:A6NDG6),PGP,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0006046,N-acetylglucosamine catabolic process,A7MBC0(Evidence code:IBA/Database source:PANTHER:PTN000121925),AMDHD2,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0008449,N-acetylglucosamine-6-sulfatase activity,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0046813,receptor-mediated virion attachment to host cell,F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens),LRRC15,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0047391,alkylglycerophosphoethanolamine phosphodiesterase activity,A1A4K5(Evidence code:IEA/Database source:EC:3.1.4.39),ENPP2,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0021772,olfactory bulb development,F1MEW1(Evidence code:IEA/Database source:UniProtKB:Q14563|ens),SEMA3A,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0031133,regulation of axon diameter,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0072178,nephric duct morphogenesis,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0046900,tetrahydrofolylpolyglutamate metabolic process,A7YWG4(Evidence code:IBA/Database source:PANTHER:PTN000140059),GGH,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0005041,low-density lipoprotein particle receptor activity,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens),LDLR,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0007597,"blood coagulation, intrinsic pathway",Q2KJ63(Evidence code:IEA/Database source:InterPro:IPR034813),KLKB1,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0032914,positive regulation of transforming growth factor beta1 production,Q05443(Evidence code:IEA/Database source:UniProtKB:P51885|ens),LUM,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0045295,gamma-catenin binding,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0003094,glomerular filtration,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:1905907,negative regulation of amyloid fibril formation,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0042954,lipoprotein transporter activity,Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6),MIA3,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0019807,aspartoacylase activity,P46446(Evidence code:IEA/Database source:EC:3.5.1.15),ASPA,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0004382,guanosine-diphosphatase activity,E1BPW0(Evidence code:IEA/Database source:EC:3.6.1.42),ENTPD5,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0032450,maltose alpha-glucosidase activity,Q9MYM4(Evidence code:IEA/Database source:EC:3.2.1.20),GAA,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0032688,negative regulation of interferon-beta production,O62830(Evidence code:ISS/Database source:UniProtKB:O75688),PPM1B,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0048672,positive regulation of collateral sprouting,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens),SEMA4D,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0008448,N-acetylglucosamine-6-phosphate deacetylase activity,A7MBC0(Evidence code:IEA/Database source:InterPro:IPR003764),AMDHD2,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0048671,negative regulation of collateral sprouting,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0001783,B cell apoptotic process,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0051919,positive regulation of fibrinolysis,Q2KJ63(Evidence code:IEA/Database source:UniProtKB:P03952|ens),KLKB1,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0034722,gamma-glutamyl-peptidase activity,A7YWG4(Evidence code:IEA/Database source:EC:3.4.19.9),GGH,MF,1,1 of 1,0.58,100,0.01068,0.03899
GO:0033693,neurofilament bundle assembly,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P12036|ens),NEFH,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0046314,phosphocreatine biosynthetic process,Q9XSC6(Evidence code:ISS/Database source:UniProtKB:P07310),CKM,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0022010,central nervous system myelination,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 1,0.58,100,0.01068,0.03899
GO:0014069,postsynaptic density,F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens)F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens), CLSTN1 NEFH,CC,2,2 of 28,1.16,7.14,0.01135,0.04126
GO:0048471,perinuclear region of cytoplasm,Q07537(Evidence code:IEA/Database source:UniProtKB:Q10472|ens)Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens)E1BBP1(Evidence code:IEA/Database source:UniProtKB:Q14435|ens), GALNT1 CLN5 SORT1 GALNT3,CC,4,4 of 170,2.31,2.35,0.0151,0.04245
GO:0007186,G-protein coupled receptor signaling pathway,O19116(Evidence code:IEA/Database source:GO:0004930)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens)E1BEC6(Evidence code:IEA/Database source:InterPro:IPR000832|I)F1MJV6(Evidence code:IEA/Database source:InterPro:IPR000832|I), SFRP1 SORT1 ADGRF1 ADGRG6,BP,4,4 of 168,2.31,2.38,0.01453,0.04245
GO:0016042,lipid catabolic process,A1A4K5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)A6H713(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442), ENPP2 PPT1 LIPA,BP,3,3 of 84,1.73,3.57,0.0118,0.04245
GO:0005765,lysosomal membrane,Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)Q9MYM4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9MYY0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), CLN5 GAA HPSE,CC,3,3 of 92,1.73,3.26,0.01492,0.04245
GO:0019221,cytokine-mediated signaling pathway,F1MMI6(Evidence code:IBA/Database source:PANTHER:PTN000043893)F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens)P21793(Evidence code:IBA/Database source:PANTHER:PTN000043893), LRRC15 IL1R1 DCN,BP,3,3 of 86,1.73,3.49,0.01254,0.04245
GO:0007507,heart development,P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens)A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens), PRKAR1A SEMA3C,BP,2,2 of 32,1.16,6.25,0.01443,0.04245
GO:0017148,negative regulation of translation,P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0652)Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens), ANG2 IGFBP5,BP,2,2 of 32,1.16,6.25,0.01443,0.04245
GO:0050660,flavin adenine dinucleotide binding,E1BBX5(Evidence code:IEA/Database source:InterPro:IPR036318)E1BKZ1(Evidence code:IEA/Database source:InterPro:IPR006322|I), AOX2 GSR,MF,2,2 of 32,1.16,6.25,0.01443,0.04245
GO:0019838,growth factor binding,Q28019(Evidence code:IEA/Database source:UniProtKB-KW:KW-0340)Q05717(Evidence code:IEA/Database source:UniProtKB-KW:KW-0340), LTBP2 IGFBP5,MF,2,2 of 29,1.16,6.9,0.01209,0.04245
GO:0008203,cholesterol metabolic process,P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0153)Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens), LDLR LCAT,BP,2,2 of 33,1.16,6.06,0.01525,0.04245
GO:0072593,reactive oxygen species metabolic process,P49259(Evidence code:ISS/Database source:UniProtKB:Q13018)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens), PLA2R1 CTGF,BP,2,2 of 29,1.16,6.9,0.01209,0.04245
GO:0001764,neuron migration,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens), CNTN2 SEMA3A,BP,2,2 of 29,1.16,6.9,0.01209,0.04245
GO:0032991,protein-containing complex,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens)E1BI98(Evidence code:IEA/Database source:UniProtKB:P12109|ens), PRKAR1A COL6A1,CC,2,2 of 1693,1.16,0.12,0.01333,0.04245
GO:0002020,protease binding,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens)F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens), LDLR IL1R1,MF,2,2 of 33,1.16,6.06,0.01525,0.04245
GO:0004860,protein kinase inhibitor activity,P21793(Evidence code:IBA/Database source:PANTHER:PTN000043893)F1MMI6(Evidence code:IBA/Database source:PANTHER:PTN000043893), DCN LRRC15,MF,2,2 of 32,1.16,6.25,0.01443,0.04245
GO:0042593,glucose homeostasis,F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), ERO1B IGFBP5,BP,2,2 of 33,1.16,6.06,0.01525,0.04245
GO:0008021,synaptic vesicle,Q0VC68(Evidence code:IEA/Database source:InterPro:IPR030647)P45478(Evidence code:ISS/Database source:UniProtKB:P50897), SEPT5 PPT1,CC,2,2 of 31,1.16,6.45,0.01363,0.04245
GO:0001649,osteoblast differentiation,P22444(Evidence code:IEA/Database source:InterPro:IPR017197)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), BMP3 IGFBP5,BP,2,2 of 29,1.16,6.9,0.01209,0.04245
GO:0001503,ossification,P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0892)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens), BMP3 CTGF,BP,2,2 of 30,1.16,6.67,0.01285,0.04245
GO:0072006,nephron development,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0016403,dimethylargininase activity,P56965(Evidence code:IEA/Database source:InterPro:IPR033197),DDAH1,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0072300,positive regulation of metanephric glomerulus development,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0032926,negative regulation of activin receptor signaling pathway,P50291(Evidence code:IEA/Database source:UniProtKB:P19883|ens),FST,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:2000345,regulation of hepatocyte proliferation,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0061549,sympathetic ganglion development,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0048549,positive regulation of pinocytosis,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0003215,cardiac right ventricle morphogenesis,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0019894,kinesin binding,F1MD95(Evidence code:IEA/Database source:UniProtKB:O94985|ens),CLSTN1,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0006624,vacuolar protein processing,Q95M12(Evidence code:IBA/Database source:PANTHER:PTN000243183),LGMN,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0006590,thyroid hormone generation,Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q6IRK9),CPQ,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:1900747,negative regulation of vascular endothelial growth factor signaling pathway,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens),DCN,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0019800,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,P21793(Evidence code:IEA/Database source:UniProtKB:P28654|ens),DCN,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0004563,beta-N-acetylhexosaminidase activity,E1BI28(Evidence code:IEA/Database source:UniProtKB:Q60648|ens),GM2A,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0034138,toll-like receptor 3 signaling pathway,A6QP79(Evidence code:IEA/Database source:UniProtKB:Q5KU26|ens),COLEC12,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0070573,metallodipeptidase activity,Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q9Y646),CPQ,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0034638,phosphatidylcholine catabolic process,A1A4K5(Evidence code:ISS/Database source:UniProtKB:Q64610),ENPP2,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0002829,negative regulation of type 2 immune response,A5D7S4(Evidence code:IEA/Database source:UniProtKB:O70394|ens),IL27RA,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0009313,oligosaccharide catabolic process,E1BI28(Evidence code:IEA/Database source:UniProtKB:Q60648|ens),GM2A,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0016540,protein autoprocessing,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens),CTSL,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0090063,positive regulation of microtubule nucleation,Q27965(Evidence code:ISS/Database source:UniProtKB:P0DMV9),HSPA1B,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0001520,outer dense fiber,P00570(Evidence code:IEA/Database source:UniProtKB:Q9R0Y5|ens),AK1,CC,1,1 of 2,0.58,50,0.01598,0.04245
GO:0030070,insulin processing,F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens),ERO1B,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0035252,UDP-xylosyltransferase activity,F1N283(Evidence code:IEA/Database source:UniProtKB:Q3U4G3|ens),XXYLT1,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0009115,xanthine catabolic process,E1BBX5(Evidence code:IBA/Database source:PANTHER:PTN000225632),AOX2,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0031290,retinal ganglion cell axon guidance,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0021853,cerebral cortex GABAergic interneuron migration,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0090102,cochlea development,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0048041,focal adhesion assembly,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0004053,arginase activity,Q2KJ64(Evidence code:IEA/Database source:InterPro:IPR014033),ARG1,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:1900038,negative regulation of cellular response to hypoxia,P56965(Evidence code:IEA/Database source:UniProtKB:O94760|ens),DDAH1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0010693,negative regulation of alkaline phosphatase activity,A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens),SEMA4D,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0042567,insulin-like growth factor ternary complex,Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens),IGFBP5,CC,1,1 of 2,0.58,50,0.01598,0.04245
GO:0048713,regulation of oligodendrocyte differentiation,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0090399,replicative senescence,P49259(Evidence code:ISS/Database source:UniProtKB:Q13018),PLA2R1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0006114,glycerol biosynthetic process,Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8),PGP,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0003148,outflow tract septum morphogenesis,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0090403,oxidative stress-induced premature senescence,P49259(Evidence code:ISS/Database source:UniProtKB:Q13018),PLA2R1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0016290,palmitoyl-CoA hydrolase activity,P45478(Evidence code:IDA/Database source:),PPT1,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0004854,xanthine dehydrogenase activity,E1BBX5(Evidence code:IBA/Database source:PANTHER:PTN000225632),AOX2,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0004528,phosphodiesterase I activity,A1A4K5(Evidence code:IEA/Database source:InterPro:IPR029881),ENPP2,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0016266,O-glycan processing,F1N283(Evidence code:IEA/Database source:UniProtKB:Q3U4G3|ens),XXYLT1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0010986,positive regulation of lipoprotein particle clearance,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0051005,negative regulation of lipoprotein lipase activity,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0060174,limb bud formation,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0001657,ureteric bud development,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0008240,tripeptidyl-peptidase activity,Q0V8B6(Evidence code:ISS/Database source:UniProtKB:O14773),TPP1,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0030200,heparan sulfate proteoglycan catabolic process,Q9MYY0(Evidence code:ISS/Database source:UniProtKB:Q9Y251),HPSE,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0016807,cysteine-type carboxypeptidase activity,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens),CTSL,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0071603,endothelial cell-cell adhesion,Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens),THBS4,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0019966,interleukin-1 binding,F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens),IL1R1,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0045657,positive regulation of monocyte differentiation,A6QL48(Evidence code:IEA/Database source:UniProtKB:Q6ZMJ4|ens),IL34,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0010756,positive regulation of plasminogen activation,E1BG25(Evidence code:IEA/Database source:UniProtKB:P08582|ens),MELTF,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0022011,myelination in peripheral nervous system,F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q6F3F9|ens),ADGRG6,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:1903077,negative regulation of protein localization to plasma membrane,F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens),LRRC15,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0090197,positive regulation of chemokine secretion,Q95M17(Evidence code:ISS/Database source:UniProtKB:Q9BZP6),CHIA,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0036477,somatodendritic compartment,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,CC,1,1 of 2,0.58,50,0.01598,0.04245
GO:0008430,selenium binding,P49907(Evidence code:IEA/Database source:InterPro:IPR037941),SELENOP,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0048011,neurotrophin TRK receptor signaling pathway,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0090110,cargo loading into COPII-coated vesicle,Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6),MIA3,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0002084,protein depalmitoylation,P45478(Evidence code:IEA/Database source:InterPro:IPR030294),PPT1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0048227,plasma membrane to endosome transport,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:2000050,regulation of non-canonical Wnt signaling pathway,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:P51654|ens),GPC3,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0070700,BMP receptor binding,P22444(Evidence code:IEA/Database source:UniProtKB:P12645|ens),BMP3,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0035497,cAMP response element binding,Q0VC23(Evidence code:IEA/Database source:InterPro:IPR029801),ATF6,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0036374,glutathione hydrolase activity,F1MYJ3(Evidence code:IEA/Database source:InterPro:IPR000101),GGT5,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:2000391,positive regulation of neutrophil extravasation,F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens),IL1R1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:2001028,positive regulation of endothelial cell chemotaxis,Q769I5(Evidence code:ISS/Database source:UniProtKB:P08581),MET,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0043517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",P49259(Evidence code:ISS/Database source:UniProtKB:Q13018),PLA2R1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0004784,superoxide dismutase activity,A3KLR9(Evidence code:IEA/Database source:InterPro:IPR018152),ECSOD,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0003828,"alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity",Q6ZXD2(Evidence code:IEA/Database source:EC:2.4.99.8),ST8SIA1,MF,1,1 of 2,0.58,50,0.01598,0.04245
GO:0071712,ER-associated misfolded protein catabolic process,Q3T083(Evidence code:IBA/Database source:PANTHER:PTN000006098),SDF2L1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0045110,intermediate filament bundle assembly,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens),NEFH,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,A6QPT7(Evidence code:IEA/Database source:InterPro:IPR033528),ERAP2,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0090238,positive regulation of arachidonic acid secretion,P49259(Evidence code:ISS/Database source:UniProtKB:Q62028),PLA2R1,BP,1,1 of 2,0.58,50,0.01598,0.04245
GO:0031225,anchored component of membrane,Q5E9X0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0336)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0336), GFRA2 GPC3,CC,2,2 of 34,1.16,5.88,0.01609,0.04262
GO:0006897,endocytosis,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens)P49259(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254), SORT1 PLA2R1 LDLR,BP,3,3 of 96,1.73,3.12,0.01665,0.04396
GO:0004888,transmembrane signaling receptor activity,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens)F1MJV6(Evidence code:IEA/Database source:InterPro:IPR017981)E1BEC6(Evidence code:IEA/Database source:InterPro:IPR017981)P49259(Evidence code:IBA/Database source:PANTHER:PTN000177070), SEMA4D ADGRG6 ADGRF1 PLA2R1,MF,4,4 of 178,2.31,2.25,0.0175,0.04608
GO:0043547,positive regulation of GTPase activity,O19116(Evidence code:IMP/Database source:)A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens), SFRP1 SEMA4D,BP,2,2 of 36,1.16,5.56,0.01783,0.04682
GO:0030335,positive regulation of cell migration,A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens)F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens)F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens), SEMA4D LRRC15 RET,BP,3,3 of 100,1.73,3,0.01847,0.04782
GO:0043231,intracellular membrane-bounded organelle,F1MS00(Evidence code:IEA/Database source:UniProtKB:A0A024R7T2)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)Q17QK3(Evidence code:IEA/Database source:UniProtKB:A0A024R9B8), RET PTPRK CPQ,CC,3,3 of 1927,1.73,0.16,0.01993,0.04782
GO:0035988,chondrocyte proliferation,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens),CTGF,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0035987,endodermal cell differentiation,E1BI98(Evidence code:IEA/Database source:UniProtKB:P12109|ens),COL6A1,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0052595,aliphatic-amine oxidase activity,Q9TTK6(Evidence code:IEA/Database source:EC:1.4.3.21),AOC3,MF,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0030151,molybdenum ion binding,Q3MHX0(Evidence code:IEA/Database source:InterPro:IPR005066),SUOX,MF,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0008474,palmitoyl-(protein) hydrolase activity,P45478(Evidence code:IEA/Database source:InterPro:IPR030294),PPT1,MF,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0004169,dolichyl-phosphate-mannose-protein mannosyltransferase activity,Q3T083(Evidence code:IBA/Database source:PANTHER:PTN000006098),SDF2L1,MF,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0060976,coronary vasculature development,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0008603,cAMP-dependent protein kinase regulator activity,P00514(Evidence code:IEA/Database source:InterPro:IPR012198),PRKAR1A,MF,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0042813,Wnt-activated receptor activity,O19116(Evidence code:IBA/Database source:PANTHER:PTN000139394),SFRP1,MF,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:2000020,positive regulation of male gonad development,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0060038,cardiac muscle cell proliferation,P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens),PRKAR1A,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0090128,regulation of synapse maturation,F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens),CLSTN1,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0098599,palmitoyl hydrolase activity,P45478(Evidence code:IEA/Database source:InterPro:IPR002472),PPT1,MF,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0051451,myoblast migration,Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens),THBS4,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0052596,phenethylamine:oxygen oxidoreductase (deaminating) activity,Q9TTK6(Evidence code:IEA/Database source:EC:1.4.3.21),AOC3,MF,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0060056,mammary gland involution,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0043030,regulation of macrophage activation,Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens),CARKL,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0006656,phosphatidylcholine biosynthetic process,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens),LCAT,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0001502,cartilage condensation,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens),CTGF,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,A7E335(Evidence code:IEA/Database source:InterPro:IPR030721),CDH16,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0060628,regulation of ER to Golgi vesicle-mediated transport,G3MXM5(Evidence code:IEA/Database source:UniProtKB:P54826|ens),GAS1,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0006689,ganglioside catabolic process,E1BI28(Evidence code:IEA/Database source:InterPro:IPR028996),GM2A,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0048407,platelet-derived growth factor binding,E1BI98(Evidence code:IEA/Database source:UniProtKB:P12109|ens),COL6A1,MF,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0060355,positive regulation of cell adhesion molecule production,A6QP79(Evidence code:IEA/Database source:UniProtKB:Q5KU26|ens),COLEC12,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0060052,neurofilament cytoskeleton organization,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens),NEFH,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0000052,citrulline metabolic process,P56965(Evidence code:IEA/Database source:InterPro:IPR033197),DDAH1,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0090435,protein localization to nuclear envelope,A5PKH0(Evidence code:IEA/Database source:UniProtKB:Q8NFQ8|ens),TOR1AIP2,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0048302,regulation of isotype switching to IgG isotypes,A5D7S4(Evidence code:IEA/Database source:UniProtKB:O70394|ens),IL27RA,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0042159,lipoprotein catabolic process,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0052594,aminoacetone:oxygen oxidoreductase(deaminating) activity,Q9TTK6(Evidence code:IEA/Database source:EC:1.4.3.21),AOC3,MF,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0044342,type B pancreatic cell proliferation,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0005883,neurofilament,F1MSQ6(Evidence code:IEA/Database source:InterPro:IPR033183),NEFH,CC,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0035970,peptidyl-threonine dephosphorylation,O62830(Evidence code:IEA/Database source:UniProtKB:O75688|ens),PPM1B,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0048013,ephrin receptor signaling pathway,F1N780(Evidence code:IEA/Database source:UniProtKB:Q15375|ens),EPHA7,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0071953,elastic fiber,Q28019(Evidence code:IDA/Database source:),LTBP2,CC,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0042551,neuron maturation,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0004622,lysophospholipase activity,A1A4K5(Evidence code:IEA/Database source:InterPro:IPR029881),ENPP2,MF,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0052593,tryptamine:oxygen oxidoreductase (deaminating) activity,Q9TTK6(Evidence code:IEA/Database source:EC:1.4.3.21),AOC3,MF,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0038180,nerve growth factor signaling pathway,E1BKZ9(Evidence code:IEA/Database source:GO:0010465),SORT1,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0006910,"phagocytosis, recognition",A6QP79(Evidence code:ISS/Database source:UniProtKB:Q5KU26),COLEC12,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0070208,protein heterotrimerization,E1BI98(Evidence code:IEA/Database source:UniProtKB:P12109|ens),COL6A1,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0045821,positive regulation of glycolytic process,E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9),ENTPD5,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0097421,liver regeneration,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0006809,nitric oxide biosynthetic process,P56965(Evidence code:IDA/Database source:),DDAH1,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0043116,negative regulation of vascular permeability,P56965(Evidence code:IEA/Database source:UniProtKB:O94760|ens),DDAH1,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0033268,node of Ranvier,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,CC,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0048266,behavioral response to pain,Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2),THBS4,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:1900025,negative regulation of substrate adhesion-dependent cell spreading,E1BG25(Evidence code:IEA/Database source:UniProtKB:P08582|ens),MELTF,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0006751,glutathione catabolic process,F1MYJ3(Evidence code:IEA/Database source:InterPro:IPR000101),GGT5,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0072111,cell proliferation involved in kidney development,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0017147,Wnt-protein binding,O19116(Evidence code:IBA/Database source:PANTHER:PTN000139394),SFRP1,MF,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0001867,"complement activation, lectin pathway",I2E4T6(Evidence code:IEA/Database source:InterPro:IPR037571),MASP2,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0002827,positive regulation of T-helper 1 type immune response,A5D7S4(Evidence code:IEA/Database source:UniProtKB:O70394|ens),IL27RA,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0033630,positive regulation of cell adhesion mediated by integrin,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0006527,arginine catabolic process,P56965(Evidence code:IEA/Database source:InterPro:IPR033197),DDAH1,BP,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0070971,endoplasmic reticulum exit site,Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6),MIA3,CC,1,1 of 3,0.58,33.33,0.02125,0.04782
GO:0005524,ATP binding,Q769I5(Evidence code:IEA/Database source:InterPro:IPR000719|I)P00570(Evidence code:IEA/Database source:InterPro:IPR000850|I)F1N780(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q27965(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q9XSC6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MS00(Evidence code:IEA/Database source:InterPro:IPR000719|I), MET AK1 EPHA7 HSPA1B CKM RET,MF,6,6 of 403,3.47,1.49,0.02494,0.05248
GO:0004930,G-protein coupled receptor activity,O19116(Evidence code:IBA/Database source:PANTHER:PTN000139394)E1BEC6(Evidence code:IEA/Database source:InterPro:IPR000832|I)F1MJV6(Evidence code:IEA/Database source:InterPro:IPR000832|I), SFRP1 ADGRF1 ADGRG6,MF,3,3 of 110,1.73,2.73,0.02351,0.05248
GO:0035116,embryonic hindlimb morphogenesis,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0035329,hippo signaling,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0048168,regulation of neuronal synaptic plasticity,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0050884,neuromuscular process controlling posture,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0034362,low-density lipoprotein particle,P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0427),LDLR,CC,1,1 of 4,0.58,25,0.0265,0.05248
GO:0014850,response to muscle activity,G3X6G7(Evidence code:IEA/Database source:InterPro:IPR039224),METRNL,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0021675,nerve development,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0008131,primary amine oxidase activity,Q9TTK6(Evidence code:IEA/Database source:InterPro:IPR000269|I),AOC3,MF,1,1 of 4,0.58,25,0.0265,0.05248
GO:0008045,motor neuron axon guidance,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0005952,cAMP-dependent protein kinase complex,P00514(Evidence code:IEA/Database source:InterPro:IPR012198),PRKAR1A,CC,1,1 of 4,0.58,25,0.0265,0.05248
GO:0019262,N-acetylneuraminate catabolic process,A7MBC0(Evidence code:IEA/Database source:UniPathway:UPA00629),AMDHD2,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0002532,production of molecular mediator involved in inflammatory response,Q95M17(Evidence code:ISS/Database source:UniProtKB:Q9BZP6),CHIA,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0006030,chitin metabolic process,Q95M17(Evidence code:IEA/Database source:InterPro:IPR002557|I),CHIA,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0035567,non-canonical Wnt signaling pathway,O19116(Evidence code:IBA/Database source:PANTHER:PTN000139394),SFRP1,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0042953,lipoprotein transport,Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6),MIA3,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0006032,chitin catabolic process,Q95M17(Evidence code:ISS/Database source:UniProtKB:Q9BZP6),CHIA,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0034663,endoplasmic reticulum chaperone complex,Q3T083(Evidence code:IEA/Database source:UniProtKB:Q9ESP1|ens),SDF2L1,CC,1,1 of 4,0.58,25,0.0265,0.05248
GO:0045651,positive regulation of macrophage differentiation,A6QL48(Evidence code:IEA/Database source:UniProtKB:Q6ZMJ4|ens),IL34,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0004111,creatine kinase activity,Q9XSC6(Evidence code:IEA/Database source:EC:2.7.3.2),CKM,MF,1,1 of 4,0.58,25,0.0265,0.05248
GO:0048185,activin binding,P50291(Evidence code:IEA/Database source:UniProtKB:P19883|ens),FST,MF,1,1 of 4,0.58,25,0.0265,0.05248
GO:0034375,high-density lipoprotein particle remodeling,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens),LCAT,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0002063,chondrocyte development,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0048706,embryonic skeletal system development,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0001838,embryonic epithelial tube formation,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0006895,Golgi to endosome transport,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0003151,outflow tract morphogenesis,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0004568,chitinase activity,Q95M17(Evidence code:IEA/Database source:EC:3.2.1.14),CHIA,MF,1,1 of 4,0.58,25,0.0265,0.05248
GO:0048484,enteric nervous system development,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0048265,response to pain,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0015020,glucuronosyltransferase activity,Q5EA01(Evidence code:ISS/Database source:UniProtKB:O43505),B4GAT1 ,MF,1,1 of 4,0.58,25,0.0265,0.05248
GO:0060347,heart trabecula formation,F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q6F3F9|ens),ADGRG6,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0070486,leukocyte aggregation,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens),SEMA4D,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0060055,angiogenesis involved in wound healing,Q9MYY0(Evidence code:IBA/Database source:PANTHER:PTN000372531),HPSE,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0070508,cholesterol import,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens),LDLR,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0050918,positive chemotaxis,Q769I5(Evidence code:ISS/Database source:UniProtKB:P08581),MET,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0030517,negative regulation of axon extension,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0051901,positive regulation of mitochondrial depolarization,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens),DCN,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0042246,tissue regeneration,Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q6IRK9),CPQ,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0034383,low-density lipoprotein particle clearance,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens),LDLR,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0031639,plasminogen activation,Q2KJ63(Evidence code:IEA/Database source:UniProtKB:P03952|ens),KLKB1,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:2000480,negative regulation of cAMP-dependent protein kinase activity,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0009948,anterior/posterior axis specification,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0005775,vacuolar lumen,Q1ZYR0(Evidence code:IEA/Database source:UniProtKB:Q3UMW8|ens),CLN5,CC,1,1 of 4,0.58,25,0.0265,0.05248
GO:0007616,long-term memory,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens),LDLR,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0043274,phospholipase binding,P49259(Evidence code:ISS/Database source:UniProtKB:Q13018-1),PLA2R1,MF,1,1 of 4,0.58,25,0.0265,0.05248
GO:0005583,fibrillar collagen trimer,Q05443(Evidence code:IEA/Database source:UniProtKB:P51884|ens),LUM,CC,1,1 of 4,0.58,25,0.0265,0.05248
GO:0005109,frizzled binding,O19116(Evidence code:IPI/Database source:UniProtKB:Q61088),SFRP1,MF,1,1 of 4,0.58,25,0.0265,0.05248
GO:0006907,pinocytosis,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0034372,very-low-density lipoprotein particle remodeling,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens),LCAT,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0010575,positive regulation of vascular endothelial growth factor production,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0004862,cAMP-dependent protein kinase inhibitor activity,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,MF,1,1 of 4,0.58,25,0.0265,0.05248
GO:0019430,removal of superoxide radicals,A3KLR9(Evidence code:IEA/Database source:GO:0004784),ECSOD,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,Q2TBL2(Evidence code:IEA/Database source:UniProtKB:Q9BY67|ens),CADM1,BP,1,1 of 4,0.58,25,0.0265,0.05248
GO:0038023,signaling receptor activity,F1MNL4(Evidence code:IEA/Database source:InterPro:IPR033024)P49259(Evidence code:ISS/Database source:UniProtKB:Q13018-1)Q5E9X0(Evidence code:IEA/Database source:InterPro:IPR003438|I)A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens), NEO1 PLA2R1 GFRA2 SEMA4D,MF,4,4 of 204,2.31,1.96,0.02687,0.05299
GO:0004672,protein kinase activity,Q769I5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N780(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MS00(Evidence code:IEA/Database source:InterPro:IPR000719|I), MET EPHA7 RET,MF,3,3 of 116,1.73,2.59,0.02685,0.05299
GO:0030336,negative regulation of cell migration,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens), PTPRK IGFBP5,BP,2,2 of 48,1.16,4.17,0.02977,0.05844
GO:0008211,glucocorticoid metabolic process,E1BF81(Evidence code:IEA/Database source:UniProtKB:Q06770|ens),SERPINA6,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0006782,protoporphyrinogen IX biosynthetic process,Q58DK5(Evidence code:IEA/Database source:UniPathway:UPA00251),ALAD,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0045879,negative regulation of smoothened signaling pathway,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0046718,viral entry into host cell,A6QLR1(Evidence code:IEA/Database source:InterPro:IPR033320),PVRL4,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0090141,positive regulation of mitochondrial fission,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens),DCN,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0098869,cellular oxidant detoxification,E1BKZ1(Evidence code:IEA/Database source:GO:0004362),GSR,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0016813,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines",Q2KJ64(Evidence code:IEA/Database source:InterPro:IPR020855),ARG1,MF,1,1 of 5,0.58,20,0.03171,0.05844
GO:1901673,regulation of mitotic spindle assembly,Q27965(Evidence code:ISS/Database source:UniProtKB:P0DMV9),HSPA1B,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0008061,chitin binding,Q95M17(Evidence code:IEA/Database source:InterPro:IPR002557|I),CHIA,MF,1,1 of 5,0.58,20,0.03171,0.05844
GO:0032801,receptor catabolic process,Q95M12(Evidence code:ISS/Database source:UniProtKB:O89017),LGMN,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0043691,reverse cholesterol transport,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens),LCAT,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0030140,trans-Golgi network transport vesicle,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens),SORT1,CC,1,1 of 5,0.58,20,0.03171,0.05844
GO:0048710,regulation of astrocyte differentiation,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0050772,positive regulation of axonogenesis,A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens),SEMA4D,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0090136,epithelial cell-cell adhesion,Q5BIR5(Evidence code:IEA/Database source:UniProtKB:P50452|ens),SERPINB8,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0000050,urea cycle,Q2KJ64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0835),ARG1,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0070412,R-SMAD binding,O62829(Evidence code:ISS/Database source:UniProtKB:P35813),PPM1A,MF,1,1 of 5,0.58,20,0.03171,0.05844
GO:0006471,protein ADP-ribosylation,Q95KW3(Evidence code:IEA/Database source:InterPro:IPR000768),ART3,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0014912,negative regulation of smooth muscle cell migration,Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens),IGFBP5,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0019509,L-methionine salvage from methylthioadenosine,Q0VD27(Evidence code:IEA/Database source:InterPro:IPR023943|I),ENOPH1,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0006044,N-acetylglucosamine metabolic process,A7MBC0(Evidence code:IEA/Database source:InterPro:IPR003764),AMDHD2,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0034236,protein kinase A catalytic subunit binding,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,MF,1,1 of 5,0.58,20,0.03171,0.05844
GO:0006465,signal peptide processing,Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503),CLN5,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0071300,cellular response to retinoic acid,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0001707,mesoderm formation,P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens),PRKAR1A,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0017014,protein nitrosylation,P56965(Evidence code:IDA/Database source:),DDAH1,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0098519,"nucleotide phosphatase activity, acting on free nucleotides",Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8),PGP,MF,1,1 of 5,0.58,20,0.03171,0.05844
GO:0097009,energy homeostasis,G3X6G7(Evidence code:IEA/Database source:UniProtKB:Q8VE43|ens),METRNL,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0031588,nucleotide-activated protein kinase complex,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,CC,1,1 of 5,0.58,20,0.03171,0.05844
GO:0046697,decidualization,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens),CTSL,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0000023,maltose metabolic process,Q9MYM4(Evidence code:IEA/Database source:GO:0032450),GAA,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0071360,cellular response to exogenous dsRNA,A6QP79(Evidence code:IEA/Database source:UniProtKB:Q5KU26|ens),COLEC12,BP,1,1 of 5,0.58,20,0.03171,0.05844
GO:0043025,neuronal cell body,F1MME1(Evidence code:IEA/Database source:UniProtKB:P35822|ens)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens), PTPRK CNTN2,CC,2,2 of 50,1.16,4,0.032,0.05885
GO:0006468,protein phosphorylation,F1MS00(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q769I5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N780(Evidence code:IEA/Database source:InterPro:IPR000719|I), RET MET EPHA7,BP,3,3 of 125,1.73,2.4,0.0323,0.0593
GO:0031175,neuron projection development,E1BPC9(Evidence code:IEA/Database source:InterPro:IPR032991)E1BEC6(Evidence code:IEA/Database source:UniProtKB:Q8VEC3|ens), CNTN2 ADGRF1,BP,2,2 of 51,1.16,3.92,0.03314,0.06059
GO:0090305,nucleic acid phosphodiester bond hydrolysis,A1A4K5(Evidence code:IEA/Database source:GO:0004528)P80929(Evidence code:IEA/Database source:GO:0004519), ENPP2 ANG2,BP,2,2 of 51,1.16,3.92,0.03314,0.06059
GO:0030154,cell differentiation,P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)O19116(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens)A7MB70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221), ANG2 SFRP1 SEMA4A CTGF SEMA3C BMP3,BP,6,6 of 434,3.47,1.38,0.03375,0.06158
GO:0006629,lipid metabolic process,A1A4K5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q2KIW4(Evidence code:IEA/Database source:InterPro:IPR003386)Q17QB3(Evidence code:IEA/Database source:InterPro:IPR016699)Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443), ENPP2 LDLR LCAT ASAH1 ST8SIA1,BP,5,5 of 325,2.89,1.54,0.03448,0.06279
GO:0000166,nucleotide binding,F1N780(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q27965(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MS00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0VC68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q769I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P00570(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P00514(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q9XSC6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547), EPHA7 HSPA1B RET SEPT5 MET AK1 PRKAR1A CKM,MF,8,8 of 677,4.62,1.18,0.035,0.06345
GO:0032496,response to lipopolysaccharide,A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849), TNFRSF6B TNFRSF21,BP,2,2 of 54,1.16,3.7,0.03664,0.06345
GO:0045926,negative regulation of growth,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), GPC3 IGFBP5,BP,2,2 of 54,1.16,3.7,0.03664,0.06345
GO:0048813,dendrite morphogenesis,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0005980,glycogen catabolic process,Q9MYM4(Evidence code:ISS/Database source:UniProtKB:P10253),GAA,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0060416,response to growth hormone,Q05717(Evidence code:IDA/Database source:),IGFBP5,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0031995,insulin-like growth factor II binding,Q05717(Evidence code:IBA/Database source:PANTHER:PTN000167605),IGFBP5,MF,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0030316,osteoclast differentiation,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0071404,cellular response to low-density lipoprotein particle stimulus,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens),LDLR,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0030552,cAMP binding,P00514(Evidence code:IEA/Database source:UniProtKB-KW:KW-0116),PRKAR1A,MF,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,Q05717(Evidence code:IBA/Database source:PANTHER:PTN000167605),IGFBP5,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:1901185,negative regulation of ERBB signaling pathway,Q95M12(Evidence code:ISS/Database source:UniProtKB:O89017),LGMN,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0051798,positive regulation of hair follicle development,P50291(Evidence code:IEA/Database source:UniProtKB:P19883|ens),FST,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0010954,positive regulation of protein processing,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0070006,metalloaminopeptidase activity,A6QPT7(Evidence code:IEA/Database source:InterPro:IPR033528),ERAP2,MF,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0051181,cofactor transport,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0002040,sprouting angiogenesis,A5D7V3(Evidence code:IEA/Database source:UniProtKB:Q9NQ30|ens),ESM1,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0046033,AMP metabolic process,P00570(Evidence code:IEA/Database source:UniRule:UR000166136),AK1,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0061564,axon development,F1MSQ6(Evidence code:IEA/Database source:InterPro:IPR033183),NEFH,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0031952,regulation of protein autophosphorylation,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0042832,defense response to protozoan,Q2KJ64(Evidence code:IEA/Database source:UniProtKB:Q61176|ens),ARG1,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0031994,insulin-like growth factor I binding,Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens),IGFBP5,MF,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0034446,substrate adhesion-dependent cell spreading,O19116(Evidence code:IDA/Database source:),SFRP1,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0010867,positive regulation of triglyceride biosynthetic process,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0004017,adenylate kinase activity,P00570(Evidence code:IEA/Database source:InterPro:IPR006267|I),AK1,MF,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0001527,microfibril,Q28019(Evidence code:IDA/Database source:),LTBP2,CC,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0008373,sialyltransferase activity,Q6ZXD2(Evidence code:IEA/Database source:InterPro:IPR001675|I),ST8SIA1,MF,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0032967,positive regulation of collagen biosynthetic process,F1MS76(Evidence code:IEA/Database source:UniProtKB:Q8C341|ens),SUCO,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0008242,omega peptidase activity,A7YWG4(Evidence code:IEA/Database source:InterPro:IPR015527),GGH,MF,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:1901862,negative regulation of muscle tissue development,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 6,0.58,16.67,0.03689,0.06345
GO:0005769,early endosome,P01131(Evidence code:ISS/Database source:UniProtKB:P01130)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens), LDLR SORT1,CC,2,2 of 55,1.16,3.64,0.03784,0.06496
GO:0042470,melanosome,Q0V8B6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7YWG4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), TPP1 GGH,CC,2,2 of 56,1.16,3.57,0.03905,0.06692
GO:0005506,iron ion binding,E1BG25(Evidence code:IEA/Database source:UniProtKB:P08582|ens)E1BBX5(Evidence code:IEA/Database source:InterPro:IPR016208), MELTF AOX2,MF,2,2 of 57,1.16,3.51,0.04028,0.0689
GO:0007416,synapse assembly,E1BEC6(Evidence code:IEA/Database source:UniProtKB:Q8VEC3|ens),ADGRF1,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0051180,vitamin transport,G3MYZ3(Evidence code:IEA/Database source:UniProtKB:P43652|ens),AFM,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0042157,lipoprotein metabolic process,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0008013,beta-catenin binding,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,MF,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0032509,endosome transport via multivesicular body sorting pathway,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0000272,polysaccharide catabolic process,Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0624),CHIA,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0048565,digestive tract development,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0051402,neuron apoptotic process,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0030201,heparan sulfate proteoglycan metabolic process,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0070498,interleukin-1-mediated signaling pathway,F1ML75(Evidence code:IEA/Database source:UniProtKB:P14778|ens),IL1R1,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0034394,protein localization to cell surface,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0090181,regulation of cholesterol metabolic process,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0046323,glucose import,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens),SORT1,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0008329,signaling pattern recognition receptor activity,A6QP79(Evidence code:ISS/Database source:UniProtKB:Q5KU26),COLEC12,MF,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0050766,positive regulation of phagocytosis,A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens),LMAN2,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0016529,sarcoplasmic reticulum,Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2),THBS4,CC,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0051085,chaperone cofactor-dependent protein refolding,A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q96HE7|ens),ERO1A ,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0045453,bone resorption,Q0V8B6(Evidence code:ISS/Database source:UniProtKB:O14773),TPP1,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0050687,negative regulation of defense response to virus,O62830(Evidence code:ISS/Database source:UniProtKB:O75688),PPM1B,BP,1,1 of 7,0.58,14.29,0.04205,0.06949
GO:0007601,visual perception,Q1ZYR0(Evidence code:IEA/Database source:UniProtKB:Q3UMW8|ens)Q05443(Evidence code:IEA/Database source:InterPro:IPR027219), CLN5 LUM,BP,2,2 of 60,1.16,3.33,0.04405,0.07266
GO:0016477,cell migration,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens)E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens), CTGF DCHS1 PTPRK,BP,3,3 of 143,1.73,2.1,0.0448,0.07376
GO:0045765,regulation of angiogenesis,O19116(Evidence code:IMP/Database source:)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR029881), SFRP1 ENPP2,BP,2,2 of 62,1.16,3.23,0.04664,0.07477
GO:0046034,ATP metabolic process,E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9)P00570(Evidence code:IEA/Database source:InterPro:IPR006267), ENTPD5 AK1,BP,2,2 of 62,1.16,3.23,0.04664,0.07477
GO:0004550,nucleoside diphosphate kinase activity,P00570(Evidence code:IEA/Database source:InterPro:IPR028582),AK1,MF,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0009086,methionine biosynthetic process,Q0VD27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0486),ENOPH1,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0051965,positive regulation of synapse assembly,F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens),CLSTN1,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0016504,peptidase activator activity,A5D7S8(Evidence code:IEA/Database source:InterPro:IPR017048),FBLN1,MF,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0051894,positive regulation of focal adhesion assembly,O19116(Evidence code:IDA/Database source:),SFRP1,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0006783,heme biosynthetic process,Q58DK5(Evidence code:ISS/Database source:UniProtKB:P13716),ALAD,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0046470,phosphatidylcholine metabolic process,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens),LCAT,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0006525,arginine metabolic process,Q2KJ64(Evidence code:IEA/Database source:InterPro:IPR014033),ARG1,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0030282,bone mineralization,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0060612,adipose tissue development,E1BKK9(Evidence code:IEA/Database source:UniProtKB:Q8VHC3|ens),SELENOM,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0030574,collagen catabolic process,Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0177),MMP2,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0010955,negative regulation of protein processing,G3MXM5(Evidence code:IEA/Database source:UniProtKB:P54826|ens),GAS1,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0001974,blood vessel remodeling,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0008543,fibroblast growth factor receptor signaling pathway,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens),CTGF,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0001671,ATPase activator activity,A5PKH0(Evidence code:IEA/Database source:UniProtKB:Q8NFQ8|ens),TOR1AIP2,MF,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0071398,cellular response to fatty acid,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0051146,striated muscle cell differentiation,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0033619,membrane protein proteolysis,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0060348,bone development,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0046326,positive regulation of glucose import,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 8,0.58,12.5,0.04718,0.07477
GO:0006139,nucleobase-containing compound metabolic process,P00570(Evidence code:IEA/Database source:InterPro:IPR000850),AK1,BP,1,1 of 1068,0.58,0.09,0.0479,0.07577
GO:0005515,protein binding,G3MYZ3(Evidence code:IPI/Database source:UniProtKB:P27467)P21793(Evidence code:IPI/Database source:UniProtKB:O18977)P00514(Evidence code:IPI/Database source:UniProtKB:P05132), AFM DCN PRKAR1A,MF,3,3 of 1669,1.73,0.18,0.05147,0.08038
GO:0050727,regulation of inflammatory response,F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens)Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens), IL1R1 CARKL,BP,2,2 of 66,1.16,3.03,0.05196,0.08038
GO:0001530,lipopolysaccharide binding,P17453(Evidence code:IEA/Database source:InterPro:IPR030181),BPI,MF,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0042026,protein refolding,Q27965(Evidence code:ISS/Database source:UniProtKB:P0DMV9),HSPA1B,BP,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0002026,regulation of the force of heart contraction,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0001756,somitogenesis,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0019933,cAMP-mediated signaling,F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q86SQ4|ens),ADGRG6,BP,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0061448,connective tissue development,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens),CTGF,BP,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0046716,muscle cell cellular homeostasis,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0004551,nucleotide diphosphatase activity,A1A4K5(Evidence code:IEA/Database source:InterPro:IPR029881),ENPP2,MF,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0046850,regulation of bone remodeling,F1MS76(Evidence code:IEA/Database source:UniProtKB:Q8C341|ens),SUCO,BP,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0016239,positive regulation of macroautophagy,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens),DCN,BP,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:2000249,regulation of actin cytoskeleton reorganization,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens),CTSL,BP,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0001954,positive regulation of cell-matrix adhesion,O19116(Evidence code:IDA/Database source:),SFRP1,BP,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0045214,sarcomere organization,P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens),PRKAR1A,BP,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0048286,lung alveolus development,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 9,0.58,11.11,0.05228,0.08038
GO:0097190,apoptotic signaling pathway,A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849), TNFRSF6B TNFRSF21,BP,2,2 of 67,1.16,2.99,0.05333,0.08185
GO:0051603,proteolysis involved in cellular protein catabolic process,Q95M12(Evidence code:ISS/Database source:UniProtKB:O89017)P25975(Evidence code:IBA/Database source:PANTHER:PTN000274640)Q0VCU3(Evidence code:IBA/Database source:PANTHER:PTN000274640), LGMN CTSL CTSF,BP,3,3 of 157,1.73,1.91,0.05593,0.08569
GO:0008333,endosome to lysosome transport,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 10,0.58,10,0.05736,0.08576
GO:0060048,cardiac muscle contraction,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P10253|ens),GAA,BP,1,1 of 10,0.58,10,0.05736,0.08576
GO:0006801,superoxide metabolic process,A3KLR9(Evidence code:IEA/Database source:InterPro:IPR001424|I),ECSOD,BP,1,1 of 10,0.58,10,0.05736,0.08576
GO:0090023,positive regulation of neutrophil chemotaxis,Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens),THBS4,BP,1,1 of 10,0.58,10,0.05736,0.08576
GO:0030057,desmosome,Q28161(Evidence code:IEA/Database source:InterPro:IPR028432),PKP1,CC,1,1 of 10,0.58,10,0.05736,0.08576
GO:0016641,"oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor",Q8MJ24(Evidence code:IEA/Database source:InterPro:IPR001695|I),LOXL4,MF,1,1 of 10,0.58,10,0.05736,0.08576
GO:0032330,regulation of chondrocyte differentiation,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens),CTGF,BP,1,1 of 10,0.58,10,0.05736,0.08576
GO:0045429,positive regulation of nitric oxide biosynthetic process,P56965(Evidence code:IEA/Database source:InterPro:IPR033197),DDAH1,BP,1,1 of 10,0.58,10,0.05736,0.08576
GO:0035264,multicellular organism growth,E1BKK9(Evidence code:IEA/Database source:UniProtKB:Q8VHC3|ens),SELENOM,BP,1,1 of 10,0.58,10,0.05736,0.08576
GO:0007628,adult walking behavior,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 10,0.58,10,0.05736,0.08576
GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,A5PJN2(Evidence code:ISS/Database source:UniProtKB:Q8R180),ERO1A ,BP,1,1 of 10,0.58,10,0.05736,0.08576
GO:0036126,sperm flagellum,P00570(Evidence code:IEA/Database source:UniProtKB:Q9R0Y5|ens),AK1,CC,1,1 of 10,0.58,10,0.05736,0.08576
GO:0045669,positive regulation of osteoblast differentiation,F1MS76(Evidence code:IEA/Database source:UniProtKB:Q8C341|ens),SUCO,BP,1,1 of 10,0.58,10,0.05736,0.08576
GO:0001772,immunological synapse,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,CC,1,1 of 10,0.58,10,0.05736,0.08576
GO:0045109,intermediate filament organization,A6QQQ9(Evidence code:ISS/Database source:UniProtKB:Q9D312),KRT20,BP,1,1 of 10,0.58,10,0.05736,0.08576
GO:0034976,response to endoplasmic reticulum stress,A5PJN2(Evidence code:ISS/Database source:UniProtKB:Q8R180)Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2), ERO1A  THBS4,BP,2,2 of 70,1.16,2.86,0.05749,0.08583
GO:0031410,cytoplasmic vesicle,A5PKI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens)P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens)F1ML49(Evidence code:IEA/Database source:UniProtKB:Q8IZA0|ens)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968), FAM3C SORT1 CTSL KIAA0319L ANG2,CC,5,5 of 379,2.89,1.32,0.05852,0.08722
GO:0043209,myelin sheath,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens), NEFH CNTN2,CC,2,2 of 71,1.16,2.82,0.05891,0.08751
GO:0045121,membrane raft,F1MS00(Evidence code:IEA/Database source:UniRule:UR000380777)P45478(Evidence code:ISS/Database source:UniProtKB:P50897), RET PPT1,CC,2,2 of 71,1.16,2.82,0.05891,0.08751
GO:0071949,FAD binding,E1BBX5(Evidence code:IEA/Database source:InterPro:IPR016166),AOX2,MF,1,1 of 11,0.58,9.09,0.06241,0.09096
GO:0019915,lipid storage,E1BI28(Evidence code:IEA/Database source:UniProtKB:Q60648|ens),GM2A,BP,1,1 of 11,0.58,9.09,0.06241,0.09096
GO:0045599,negative regulation of fat cell differentiation,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens),SORT1,BP,1,1 of 11,0.58,9.09,0.06241,0.09096
GO:0048814,regulation of dendrite morphogenesis,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens),SEMA4D,BP,1,1 of 11,0.58,9.09,0.06241,0.09096
GO:0009395,phospholipid catabolic process,A1A4K5(Evidence code:ISS/Database source:UniProtKB:Q13822),ENPP2,BP,1,1 of 11,0.58,9.09,0.06241,0.09096
GO:0071320,cellular response to cAMP,Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens),IGFBP5,BP,1,1 of 11,0.58,9.09,0.06241,0.09096
GO:0048038,quinone binding,Q9TTK6(Evidence code:IEA/Database source:InterPro:IPR000269|I),AOC3,MF,1,1 of 11,0.58,9.09,0.06241,0.09096
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens),SEMA4D,BP,1,1 of 11,0.58,9.09,0.06241,0.09096
GO:0050852,T cell receptor signaling pathway,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 11,0.58,9.09,0.06241,0.09096
GO:0005771,multivesicular body,P01131(Evidence code:IDA/Database source:),LDLR,CC,1,1 of 11,0.58,9.09,0.06241,0.09096
GO:0071560,cellular response to transforming growth factor beta stimulus,E1BIR5(Evidence code:IEA/Database source:UniProtKB:O75339|ens),CILP,BP,1,1 of 11,0.58,9.09,0.06241,0.09096
GO:0051209,release of sequestered calcium ion into cytosol,A5PJN2(Evidence code:ISS/Database source:UniProtKB:Q8R180),ERO1A ,BP,1,1 of 11,0.58,9.09,0.06241,0.09096
GO:0005856,cytoskeleton,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P12036|ens)Q0VC68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q27965(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206), NEFH SEPT5 HSPA1B,CC,3,3 of 165,1.73,1.82,0.06282,0.09142
GO:0098797,plasma membrane protein complex,F1MNL4(Evidence code:IEA/Database source:UniProtKB:Q92859|ens)F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens), NEO1 RET,CC,2,2 of 76,1.16,2.63,0.06615,0.09611
GO:0006493,protein O-linked glycosylation,Q07537(Evidence code:IEA/Database source:UniProtKB:O08912|ens),GALNT1,BP,1,1 of 12,0.58,8.33,0.06743,0.09691
GO:0006779,porphyrin-containing compound biosynthetic process,Q58DK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0627),ALAD,BP,1,1 of 12,0.58,8.33,0.06743,0.09691
GO:0010596,negative regulation of endothelial cell migration,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens),DCN,BP,1,1 of 12,0.58,8.33,0.06743,0.09691
GO:0007613,memory,E1BEC6(Evidence code:IEA/Database source:UniProtKB:Q8VEC3|ens),ADGRF1,BP,1,1 of 12,0.58,8.33,0.06743,0.09691
GO:0016763,"transferase activity, transferring pentosyl groups",A5PJH9(Evidence code:IEA/Database source:InterPro:IPR018016),UPP1,MF,1,1 of 12,0.58,8.33,0.06743,0.09691
GO:0007029,endoplasmic reticulum organization,A5PKH0(Evidence code:IEA/Database source:UniProtKB:Q8NFQ8|ens),TOR1AIP2,BP,1,1 of 12,0.58,8.33,0.06743,0.09691
GO:0043525,positive regulation of neuron apoptotic process,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 12,0.58,8.33,0.06743,0.09691
GO:0000226,microtubule cytoskeleton organization,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens)F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens), CNTN2 NEFH,BP,2,2 of 77,1.16,2.6,0.06763,0.09705
GO:1901799,negative regulation of proteasomal protein catabolic process,Q58DK5(Evidence code:IEA/Database source:UniProtKB:P13716|ens),ALAD,BP,1,1 of 13,0.58,7.69,0.07242,0.102
GO:0048662,negative regulation of smooth muscle cell proliferation,Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens),IGFBP5,BP,1,1 of 13,0.58,7.69,0.07242,0.102
GO:0007179,transforming growth factor beta receptor signaling pathway,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,BP,1,1 of 13,0.58,7.69,0.07242,0.102
GO:0031579,membrane raft organization,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 13,0.58,7.69,0.07242,0.102
GO:0030199,collagen fibril organization,Q05443(Evidence code:IEA/Database source:InterPro:IPR027219),LUM,BP,1,1 of 13,0.58,7.69,0.07242,0.102
GO:0035690,cellular response to drug,E1BE60(Evidence code:IEA/Database source:UniProtKB:Q91VC7|ens),PPP1R14A,BP,1,1 of 13,0.58,7.69,0.07242,0.102
GO:0009791,post-embryonic development,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 13,0.58,7.69,0.07242,0.102
GO:0032781,positive regulation of ATPase activity,A5PKH0(Evidence code:IEA/Database source:UniProtKB:Q8NFQ8|ens),TOR1AIP2,BP,1,1 of 13,0.58,7.69,0.07242,0.102
GO:0009409,response to cold,G3X6G7(Evidence code:IEA/Database source:InterPro:IPR039224),METRNL,BP,1,1 of 13,0.58,7.69,0.07242,0.102
GO:0003073,regulation of systemic arterial blood pressure,P56965(Evidence code:IEA/Database source:UniProtKB:Q9CWS0|ens),DDAH1,BP,1,1 of 13,0.58,7.69,0.07242,0.102
GO:0034364,high-density lipoprotein particle,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens),LCAT,CC,1,1 of 13,0.58,7.69,0.07242,0.102
GO:0048260,positive regulation of receptor-mediated endocytosis,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 13,0.58,7.69,0.07242,0.102
GO:0045944,positive regulation of transcription by RNA polymerase II,Q0VC23(Evidence code:IEA/Database source:InterPro:IPR029801)Q05443(Evidence code:IEA/Database source:UniProtKB:P51885|ens)P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens), ATF6 LUM DCN,BP,3,3 of 177,1.73,1.69,0.07384,0.1039
GO:0007565,female pregnancy,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 14,0.58,7.14,0.07739,0.1079
GO:0008374,O-acyltransferase activity,Q2KIW4(Evidence code:IEA/Database source:InterPro:IPR003386),LCAT,MF,1,1 of 14,0.58,7.14,0.07739,0.1079
GO:0031594,neuromuscular junction,P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens),PRKAR1A,CC,1,1 of 14,0.58,7.14,0.07739,0.1079
GO:0060070,canonical Wnt signaling pathway,O19116(Evidence code:IBA/Database source:PANTHER:PTN000139394),SFRP1,BP,1,1 of 14,0.58,7.14,0.07739,0.1079
GO:0033014,tetrapyrrole biosynthetic process,Q58DK5(Evidence code:IEA/Database source:InterPro:IPR001731),ALAD,BP,1,1 of 14,0.58,7.14,0.07739,0.1079
GO:0009166,nucleotide catabolic process,A5PJH9(Evidence code:IEA/Database source:InterPro:IPR010059),UPP1,BP,1,1 of 14,0.58,7.14,0.07739,0.1079
GO:0005125,cytokine activity,P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)A6QL48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202), BMP3 IL34,MF,2,2 of 84,1.16,2.38,0.0783,0.109
GO:0045104,intermediate filament cytoskeleton organization,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens),NEFH,BP,1,1 of 15,0.58,6.67,0.08233,0.1127
GO:0050806,positive regulation of synaptic transmission,F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens),CLSTN1,BP,1,1 of 15,0.58,6.67,0.08233,0.1127
GO:0001750,photoreceptor outer segment,F1MME1(Evidence code:IEA/Database source:UniProtKB:P35822|ens),PTPRK,CC,1,1 of 15,0.58,6.67,0.08233,0.1127
GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,P22444(Evidence code:IBA/Database source:PANTHER:PTN000218063),BMP3,BP,1,1 of 15,0.58,6.67,0.08233,0.1127
GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens),LMAN2,CC,1,1 of 15,0.58,6.67,0.08233,0.1127
GO:0004177,aminopeptidase activity,A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0031),ERAP2,MF,1,1 of 15,0.58,6.67,0.08233,0.1127
GO:0071230,cellular response to amino acid stimulus,E1BI98(Evidence code:IEA/Database source:UniProtKB:Q04857|ens),COL6A1,BP,1,1 of 15,0.58,6.67,0.08233,0.1127
GO:0030165,PDZ domain binding,F1MW38(Evidence code:IEA/Database source:UniProtKB:Q9NZV1|ens),CRIM1,MF,1,1 of 15,0.58,6.67,0.08233,0.1127
GO:0005160,transforming growth factor beta receptor binding,P22444(Evidence code:IBA/Database source:PANTHER:PTN000218063),BMP3,MF,1,1 of 15,0.58,6.67,0.08233,0.1127
GO:0030509,BMP signaling pathway,P22444(Evidence code:IBA/Database source:PANTHER:PTN000218210),BMP3,BP,1,1 of 15,0.58,6.67,0.08233,0.1127
GO:0005604,basement membrane,Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens),THBS4,CC,1,1 of 15,0.58,6.67,0.08233,0.1127
GO:0008289,lipid binding,E1BF81(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)P17453(Evidence code:IEA/Database source:InterPro:IPR001124|I)Q0PH99(Evidence code:IEA/Database source:InterPro:IPR017942|I), SERPINA6 BPI BSP30C,MF,3,3 of 190,1.73,1.58,0.08667,0.1169
GO:0015914,phospholipid transport,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0007229,integrin-mediated signaling pathway,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens),CTGF,BP,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0046330,positive regulation of JNK cascade,O18739(Evidence code:IEA/Database source:UniProtKB:P29279|ens),CTGF,BP,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0008076,voltage-gated potassium channel complex,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,CC,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0051537,"2 iron, 2 sulfur cluster binding",E1BBX5(Evidence code:IEA/Database source:InterPro:IPR006058),AOX2,MF,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0034103,regulation of tissue remodeling,Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2),THBS4,BP,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0071897,DNA biosynthetic process,O18739(Evidence code:IEA/Database source:UniProtKB-KW:KW-0237),CTGF,BP,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0004180,carboxypeptidase activity,Q17QK3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0121),CPQ,MF,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0033141,positive regulation of peptidyl-serine phosphorylation of STAT protein,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0009308,amine metabolic process,Q9TTK6(Evidence code:IEA/Database source:InterPro:IPR000269|I),AOC3,BP,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0010508,positive regulation of autophagy,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens),DCN,BP,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0010633,negative regulation of epithelial cell migration,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0007612,learning,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0043621,protein self-association,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,MF,1,1 of 16,0.58,6.25,0.08724,0.1169
GO:0006644,phospholipid metabolic process,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens)A1A4K5(Evidence code:IEA/Database source:UniProtKB:Q9R1E6|ens), LCAT ENPP2,BP,2,2 of 91,1.16,2.2,0.08945,0.1197
GO:0002027,regulation of heart rate,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 17,0.58,5.88,0.09213,0.1217
GO:0051117,ATPase binding,A5PKH0(Evidence code:IEA/Database source:UniProtKB:Q8NFQ8|ens),TOR1AIP2,MF,1,1 of 17,0.58,5.88,0.09213,0.1217
GO:0090090,negative regulation of canonical Wnt signaling pathway,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 17,0.58,5.88,0.09213,0.1217
GO:0051084,de novo posttranslational protein folding,E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9),ENTPD5,BP,1,1 of 17,0.58,5.88,0.09213,0.1217
GO:0006941,striated muscle contraction,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 17,0.58,5.88,0.09213,0.1217
GO:0006890,"retrograde vesicle-mediated transport, Golgi to ER",A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens),LMAN2,BP,1,1 of 17,0.58,5.88,0.09213,0.1217
GO:0005930,axoneme,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,CC,1,1 of 17,0.58,5.88,0.09213,0.1217
GO:0001938,positive regulation of endothelial cell proliferation,Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens),THBS4,BP,1,1 of 17,0.58,5.88,0.09213,0.1217
GO:0006986,response to unfolded protein,Q3SWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0834),THBS4,BP,1,1 of 17,0.58,5.88,0.09213,0.1217
GO:0010468,regulation of gene expression,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 870,0.58,0.11,0.096,0.1266
GO:0019205,nucleobase-containing compound kinase activity,P00570(Evidence code:IEA/Database source:InterPro:IPR000850),AK1,MF,1,1 of 18,0.58,5.56,0.09699,0.1268
GO:0000187,activation of MAPK activity,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 18,0.58,5.56,0.09699,0.1268
GO:0031623,receptor internalization,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 18,0.58,5.56,0.09699,0.1268
GO:0007417,central nervous system development,Q0V8B6(Evidence code:IBA/Database source:PANTHER:PTN001022357),TPP1,BP,1,1 of 18,0.58,5.56,0.09699,0.1268
GO:0030136,clathrin-coated vesicle,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,CC,1,1 of 18,0.58,5.56,0.09699,0.1268
GO:0050661,NADP binding,E1BKZ1(Evidence code:IEA/Database source:InterPro:IPR006322),GSR,MF,1,1 of 18,0.58,5.56,0.09699,0.1268
GO:0005901,caveola,P01131(Evidence code:IDA/Database source:),LDLR,CC,1,1 of 19,0.58,5.26,0.1018,0.1324
GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000559028),TNFRSF6B,BP,1,1 of 19,0.58,5.26,0.1018,0.1324
GO:0050770,regulation of axonogenesis,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 19,0.58,5.26,0.1018,0.1324
GO:0048771,tissue remodeling,Q3SWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0797),THBS4,BP,1,1 of 19,0.58,5.26,0.1018,0.1324
GO:0005634,nucleus,P46446(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0VC23(Evidence code:IEA/Database source:InterPro:IPR029801)O62829(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7MBC0(Evidence code:IBA/Database source:PANTHER:PTN000874110)P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens)Q0VD27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q9MYY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q28161(Evidence code:IEA/Database source:InterPro:IPR028432), ASPA PPT1 ANG2 MMP2 ATF6 PPM1A AMDHD2 CTSL ENOPH1 HPSE PKP1,CC,11,11 of 1172,6.36,0.94,0.1022,0.1327
GO:0001934,positive regulation of protein phosphorylation,A6QL48(Evidence code:IEA/Database source:InterPro:IPR020415)A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens)F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens), IL34 SEMA4D EPHA7,BP,3,3 of 205,1.73,1.46,0.1025,0.1329
GO:0010977,negative regulation of neuron projection development,F1MEW1(Evidence code:IEA/Database source:UniProtKB:Q14563|ens),SEMA3A,BP,1,1 of 20,0.58,5,0.1066,0.1367
GO:0008037,cell recognition,Q2TBL2(Evidence code:IEA/Database source:UniProtKB:Q9BY67|ens),CADM1,BP,1,1 of 20,0.58,5,0.1066,0.1367
GO:0016811,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides",P46446(Evidence code:IEA/Database source:InterPro:IPR016708),ASPA,MF,1,1 of 20,0.58,5,0.1066,0.1367
GO:0030177,positive regulation of Wnt signaling pathway,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8IWU5|ens),SULF2,BP,1,1 of 20,0.58,5,0.1066,0.1367
GO:0060395,SMAD protein signal transduction,P22444(Evidence code:IBA/Database source:PANTHER:PTN000218063),BMP3,BP,1,1 of 20,0.58,5,0.1066,0.1367
GO:0010906,regulation of glucose metabolic process,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 20,0.58,5,0.1066,0.1367
GO:0005811,lipid droplet,F1ME65(Evidence code:IEA/Database source:UniProtKB:Q07065|ens),CKAP4,CC,1,1 of 20,0.58,5,0.1066,0.1367
GO:0006749,glutathione metabolic process,E1BKZ1(Evidence code:IEA/Database source:InterPro:IPR006322),GSR,BP,1,1 of 20,0.58,5,0.1066,0.1367
GO:0002376,immune system process,Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)A6QL48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391), SEMA4A IL34 ERAP2 CHIA,BP,4,4 of 334,2.31,1.2,0.1109,0.1405
GO:0010008,endosome membrane,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens)Q28193(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), RET FURIN,CC,2,2 of 104,1.16,1.92,0.1113,0.1405
GO:0006165,nucleoside diphosphate phosphorylation,P00570(Evidence code:ISS/Database source:UniProtKB:P00568),AK1,BP,1,1 of 21,0.58,4.76,0.1114,0.1405
GO:0099003,vesicle-mediated transport in synapse,F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens),CLSTN1,BP,1,1 of 21,0.58,4.76,0.1114,0.1405
GO:0050715,positive regulation of cytokine secretion,Q2TBL2(Evidence code:IEA/Database source:UniProtKB:Q9BY67|ens),CADM1,BP,1,1 of 21,0.58,4.76,0.1114,0.1405
GO:0001816,cytokine production,P49259(Evidence code:ISS/Database source:UniProtKB:Q13018),PLA2R1,BP,1,1 of 21,0.58,4.76,0.1114,0.1405
GO:0002244,hematopoietic progenitor cell differentiation,P50291(Evidence code:IEA/Database source:UniProtKB:P19883|ens),FST,BP,1,1 of 21,0.58,4.76,0.1114,0.1405
GO:0034614,cellular response to reactive oxygen species,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,BP,1,1 of 21,0.58,4.76,0.1114,0.1405
GO:0003014,renal system process,Q95M12(Evidence code:ISS/Database source:UniProtKB:O89017),LGMN,BP,1,1 of 21,0.58,4.76,0.1114,0.1405
GO:0009611,response to wounding,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 21,0.58,4.76,0.1114,0.1405
GO:0055072,iron ion homeostasis,F1MNL4(Evidence code:IEA/Database source:InterPro:IPR033024),NEO1,BP,1,1 of 21,0.58,4.76,0.1114,0.1405
GO:0010976,positive regulation of neuron projection development,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 21,0.58,4.76,0.1114,0.1405
GO:0019901,protein kinase binding,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P12036|ens), PTPRK NEFH,MF,2,2 of 106,1.16,1.89,0.1147,0.1445
GO:0006487,protein N-linked glycosylation,E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9),ENTPD5,BP,1,1 of 22,0.58,4.55,0.1162,0.1451
GO:0034644,cellular response to UV,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,BP,1,1 of 22,0.58,4.55,0.1162,0.1451
GO:0032580,Golgi cisterna membrane,Q07537(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),GALNT1,CC,1,1 of 22,0.58,4.55,0.1162,0.1451
GO:0071356,cellular response to tumor necrosis factor,Q08DN1(Evidence code:IEA/Database source:UniProtKB:O75509|ens),TNFRSF21,BP,1,1 of 22,0.58,4.55,0.1162,0.1451
GO:0030426,growth cone,F1MCA2(Evidence code:IEA/Database source:UniProtKB:Q91XX8|ens),PCDHGB1,CC,1,1 of 22,0.58,4.55,0.1162,0.1451
GO:0005977,glycogen metabolic process,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 22,0.58,4.55,0.1162,0.1451
GO:0016903,"oxidoreductase activity, acting on the aldehyde or oxo group of donors",E1BBX5(Evidence code:IBA/Database source:PANTHER:PTN000225632),AOX2,MF,1,1 of 23,0.58,4.35,0.1209,0.1506
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9),ENTPD5,BP,1,1 of 23,0.58,4.35,0.1209,0.1506
GO:0042147,"retrograde transport, endosome to Golgi",Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503),CLN5,BP,1,1 of 24,0.58,4.17,0.1256,0.1559
GO:0044853,plasma membrane raft,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,CC,1,1 of 24,0.58,4.17,0.1256,0.1559
GO:0070555,response to interleukin-1,F1ML75(Evidence code:IEA/Database source:UniProtKB:P14778|ens),IL1R1,BP,1,1 of 24,0.58,4.17,0.1256,0.1559
GO:0032868,response to insulin,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens),SORT1,BP,1,1 of 25,0.58,4,0.1303,0.161
GO:0050729,positive regulation of inflammatory response,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 25,0.58,4,0.1303,0.161
GO:0004222,metalloendopeptidase activity,Q9GLE5(Evidence code:IEA/Database source:InterPro:IPR001818|I),MMP2,MF,1,1 of 25,0.58,4,0.1303,0.161
GO:0000122,negative regulation of transcription by RNA polymerase II,A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens)P50291(Evidence code:IEA/Database source:UniProtKB:P19883|ens), SEMA4D FST,BP,2,2 of 115,1.16,1.74,0.1307,0.1613
GO:0005730,nucleolus,P80929(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)O62830(Evidence code:IEA/Database source:UniProtKB:O75688|ens)P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens), ANG2 PPM1B CTSL,CC,3,3 of 232,1.73,1.29,0.1337,0.1648
GO:0009408,response to heat,Q9XSC6(Evidence code:ISS/Database source:UniProtKB:P00565),CKM,BP,1,1 of 26,0.58,3.85,0.1349,0.1655
GO:0071222,cellular response to lipopolysaccharide,Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens),CARKL,BP,1,1 of 26,0.58,3.85,0.1349,0.1655
GO:0031256,leading edge membrane,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,CC,1,1 of 26,0.58,3.85,0.1349,0.1655
GO:0031072,heat shock protein binding,A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens),LMAN2,MF,1,1 of 26,0.58,3.85,0.1349,0.1655
GO:0036094,small molecule binding,G3X701(Evidence code:IEA/Database source:InterPro:IPR002345),LOC100300091,MF,1,1 of 800,0.58,0.12,0.1361,0.1666
GO:0043169,cation binding,O62829(Evidence code:IEA/Database source:InterPro:IPR000222)O62830(Evidence code:IEA/Database source:InterPro:IPR000222), PPM1A PPM1B,MF,2,2 of 1145,1.16,0.17,0.1375,0.1682
GO:0007050,cell cycle arrest,P00570(Evidence code:IEA/Database source:UniProtKB:Q9R0Y5|ens),AK1,BP,1,1 of 27,0.58,3.7,0.1396,0.1691
GO:0005496,steroid binding,E1BF81(Evidence code:ISS/Database source:UniProtKB:P08185),SERPINA6,MF,1,1 of 27,0.58,3.7,0.1396,0.1691
GO:0050728,negative regulation of inflammatory response,G3X6G7(Evidence code:IEA/Database source:InterPro:IPR039224),METRNL,BP,1,1 of 27,0.58,3.7,0.1396,0.1691
GO:0001894,tissue homeostasis,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens),CTGF,BP,1,1 of 27,0.58,3.7,0.1396,0.1691
GO:0051781,positive regulation of cell division,Q3SWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0497),THBS4,BP,1,1 of 27,0.58,3.7,0.1396,0.1691
GO:0051287,NAD binding,E1BBX5(Evidence code:IEA/Database source:InterPro:IPR014313),AOX2,MF,1,1 of 27,0.58,3.7,0.1396,0.1691
GO:0050680,negative regulation of epithelial cell proliferation,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 27,0.58,3.7,0.1396,0.1691
GO:0010634,positive regulation of epithelial cell migration,A1A4K5(Evidence code:IEA/Database source:UniProtKB:Q13822|ens),ENPP2,BP,1,1 of 28,0.58,3.57,0.1442,0.1738
GO:0007611,learning or memory,E1BI28(Evidence code:IEA/Database source:UniProtKB:Q60648|ens),GM2A,BP,1,1 of 28,0.58,3.57,0.1442,0.1738
GO:0042383,sarcolemma,E1BI98(Evidence code:IEA/Database source:UniProtKB:Q04857|ens),COL6A1,CC,1,1 of 28,0.58,3.57,0.1442,0.1738
GO:0000786,nucleosome,F1MSQ6(Evidence code:IEA/Database source:InterPro:IPR005819),NEFH,CC,1,1 of 28,0.58,3.57,0.1442,0.1738
GO:0045665,negative regulation of neuron differentiation,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 29,0.58,3.45,0.1488,0.1791
GO:0042802,identical protein binding,P00514(Evidence code:IPI/Database source:UniProtKB:P00514)A6QLR1(Evidence code:IEA/Database source:UniProtKB:Q96NY8|ens)Q58DK5(Evidence code:IEA/Database source:UniProtKB:P10518|ens)P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens), PRKAR1A PVRL4 ALAD LDLR,MF,4,4 of 379,2.31,1.06,0.1529,0.1838
GO:0043524,negative regulation of neuron apoptotic process,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 30,0.58,3.33,0.1533,0.1841
GO:0030308,negative regulation of cell growth,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 31,0.58,3.23,0.1578,0.1883
GO:0000048,peptidyltransferase activity,F1MYJ3(Evidence code:IEA/Database source:UniProtKB:P36269|ens),GGT5,MF,1,1 of 31,0.58,3.23,0.1578,0.1883
GO:0050830,defense response to Gram-positive bacterium,A5D7S4(Evidence code:IEA/Database source:UniProtKB:O70394|ens),IL27RA,BP,1,1 of 31,0.58,3.23,0.1578,0.1883
GO:0000165,MAPK cascade,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 31,0.58,3.23,0.1578,0.1883
GO:0030182,neuron differentiation,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 31,0.58,3.23,0.1578,0.1883
GO:0010952,positive regulation of peptidase activity,A5D7S8(Evidence code:IEA/Database source:GO:0016504),FBLN1,BP,1,1 of 32,0.58,3.12,0.1623,0.1927
GO:0050829,defense response to Gram-negative bacterium,P17453(Evidence code:IEA/Database source:InterPro:IPR030181),BPI,BP,1,1 of 32,0.58,3.12,0.1623,0.1927
GO:0006888,ER to Golgi vesicle-mediated transport,Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6),MIA3,BP,1,1 of 32,0.58,3.12,0.1623,0.1927
GO:0005581,collagen trimer,A6QP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176),COLEC12,CC,1,1 of 32,0.58,3.12,0.1623,0.1927
GO:0006334,nucleosome assembly,F1MSQ6(Evidence code:IEA/Database source:InterPro:IPR005819),NEFH,BP,1,1 of 33,0.58,3.03,0.1668,0.1975
GO:0045444,fat cell differentiation,G3X6G7(Evidence code:IEA/Database source:UniProtKB:Q8VE43|ens),METRNL,BP,1,1 of 33,0.58,3.03,0.1668,0.1975
GO:0015031,protein transport,P45478(Evidence code:ISS/Database source:UniProtKB:P50897)Q2HJD1(Evidence code:IEA/Database source:UniProtKB:Q9H0V9|ens)Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6)G3MYZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653), PPT1 LMAN2L MIA3 AFM,BP,4,4 of 394,2.31,1.02,0.168,0.1986
GO:0060828,regulation of canonical Wnt signaling pathway,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:P51654|ens),GPC3,BP,1,1 of 34,0.58,2.94,0.1713,0.2018
GO:0008652,cellular amino acid biosynthetic process,Q0VD27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0028),ENOPH1,BP,1,1 of 34,0.58,2.94,0.1713,0.2018
GO:0005788,endoplasmic reticulum lumen,Q3T083(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),SDF2L1,CC,1,1 of 34,0.58,2.94,0.1713,0.2018
GO:0009267,cellular response to starvation,A6QQQ9(Evidence code:ISS/Database source:UniProtKB:Q9D312),KRT20,BP,1,1 of 35,0.58,2.86,0.1757,0.2065
GO:0090501,RNA phosphodiester bond hydrolysis,P80929(Evidence code:IEA/Database source:GO:0004540),ANG2,BP,1,1 of 35,0.58,2.86,0.1757,0.2065
GO:0030176,integral component of endoplasmic reticulum membrane,F1N283(Evidence code:IEA/Database source:UniProtKB:Q8NBI6|ens),XXYLT1,CC,1,1 of 36,0.58,2.78,0.1801,0.2108
GO:0006665,sphingolipid metabolic process,Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0746),ST8SIA1,BP,1,1 of 36,0.58,2.78,0.1801,0.2108
GO:0010769,regulation of cell morphogenesis involved in differentiation,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 36,0.58,2.78,0.1801,0.2108
GO:0016810,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",A7MBC0(Evidence code:IEA/Database source:InterPro:IPR011059),AMDHD2,MF,1,1 of 37,0.58,2.7,0.1845,0.2154
GO:0008022,protein C-terminus binding,O18739(Evidence code:IEA/Database source:UniProtKB:P29279|ens),CTGF,MF,1,1 of 37,0.58,2.7,0.1845,0.2154
GO:0040008,regulation of growth,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), GPC3 IGFBP5,BP,2,2 of 145,1.16,1.38,0.1867,0.2176
GO:0004540,ribonuclease activity,P80929(Evidence code:IBA/Database source:PANTHER:PTN001350296),ANG2,MF,1,1 of 38,0.58,2.63,0.1889,0.2191
GO:0006006,glucose metabolic process,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 38,0.58,2.63,0.1889,0.2191
GO:0045732,positive regulation of protein catabolic process,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 38,0.58,2.63,0.1889,0.2191
GO:0045930,negative regulation of mitotic cell cycle,G3MXM5(Evidence code:IEA/Database source:UniProtKB:P54826|ens),GAS1,BP,1,1 of 38,0.58,2.63,0.1889,0.2191
GO:0042393,histone binding,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens),CTSL,MF,1,1 of 39,0.58,2.56,0.1932,0.2231
GO:0007626,locomotory behavior,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 39,0.58,2.56,0.1932,0.2231
GO:0009142,nucleoside triphosphate biosynthetic process,P00570(Evidence code:IEA/Database source:InterPro:IPR028582),AK1,BP,1,1 of 39,0.58,2.56,0.1932,0.2231
GO:0007162,negative regulation of cell adhesion,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens),SEMA4D,BP,1,1 of 39,0.58,2.56,0.1932,0.2231
GO:0010629,negative regulation of gene expression,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens)P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens)E1BIR5(Evidence code:IEA/Database source:UniProtKB:O75339|ens), CTGF LDLR CILP,BP,3,3 of 281,1.73,1.07,0.1967,0.2268
GO:0042445,hormone metabolic process,E1BKK9(Evidence code:IEA/Database source:UniProtKB:Q8VHC3|ens),SELENOM,BP,1,1 of 40,0.58,2.5,0.1975,0.2272
GO:0051536,iron-sulfur cluster binding,E1BBX5(Evidence code:IEA/Database source:InterPro:IPR001041|I),AOX2,MF,1,1 of 40,0.58,2.5,0.1975,0.2272
GO:0051606,detection of stimulus,Q2TBL2(Evidence code:IEA/Database source:UniProtKB:Q9BY67|ens),CADM1,BP,1,1 of 41,0.58,2.44,0.2018,0.2313
GO:0005770,late endosome,P01131(Evidence code:ISS/Database source:UniProtKB:P01130),LDLR,CC,1,1 of 41,0.58,2.44,0.2018,0.2313
GO:0016323,basolateral plasma membrane,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,CC,1,1 of 41,0.58,2.44,0.2018,0.2313
GO:0070374,positive regulation of ERK1 and ERK2 cascade,O18739(Evidence code:IEA/Database source:UniProtKB:P29279|ens),CTGF,BP,1,1 of 42,0.58,2.38,0.2061,0.2359
GO:0008360,regulation of cell shape,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens),SEMA4D,BP,1,1 of 43,0.58,2.33,0.2103,0.2398
GO:0017157,regulation of exocytosis,Q0VC68(Evidence code:IEA/Database source:InterPro:IPR030647),SEPT5,BP,1,1 of 43,0.58,2.33,0.2103,0.2398
GO:0007218,neuropeptide signaling pathway,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 43,0.58,2.33,0.2103,0.2398
GO:0016485,protein processing,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens),CTSL,BP,1,1 of 44,0.58,2.27,0.2146,0.2441
GO:0072659,protein localization to plasma membrane,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 44,0.58,2.27,0.2146,0.2441
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 45,0.58,2.22,0.2188,0.2479
GO:0008217,regulation of blood pressure,A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000745637),ERAP2,BP,1,1 of 45,0.58,2.22,0.2188,0.2479
GO:0009116,nucleoside metabolic process,A5PJH9(Evidence code:IEA/Database source:InterPro:IPR000845|I),UPP1,BP,1,1 of 45,0.58,2.22,0.2188,0.2479
GO:0009055,electron transfer activity,E1BBX5(Evidence code:IEA/Database source:InterPro:IPR001041|I),AOX2,MF,1,1 of 46,0.58,2.17,0.223,0.2524
GO:0008284,positive regulation of cell proliferation,A5D7V3(Evidence code:IEA/Database source:UniProtKB:Q9NQ30|ens)A6QL48(Evidence code:IEA/Database source:InterPro:IPR020415), ESM1 IL34,BP,2,2 of 164,1.16,1.22,0.2236,0.2527
GO:0005768,endosome,Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967), FURIN LDLR,CC,2,2 of 165,1.16,1.21,0.2255,0.2546
GO:0050821,protein stabilization,G3MYZ3(Evidence code:IEA/Database source:UniProtKB:P43652|ens),AFM,BP,1,1 of 47,0.58,2.13,0.2271,0.2561
GO:0007389,pattern specification process,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 48,0.58,2.08,0.2312,0.2605
GO:0020037,heme binding,Q3MHX0(Evidence code:IEA/Database source:InterPro:IPR018506),SUOX,MF,1,1 of 49,0.58,2.04,0.2354,0.2645
GO:0007268,chemical synaptic transmission,P45478(Evidence code:IBA/Database source:PANTHER:PTN000133985),PPT1,BP,1,1 of 49,0.58,2.04,0.2354,0.2645
GO:0030425,dendrite,F1MME1(Evidence code:IEA/Database source:UniProtKB:P35822|ens),PTPRK,CC,1,1 of 50,0.58,2,0.2394,0.2681
GO:0006887,exocytosis,Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6),MIA3,BP,1,1 of 50,0.58,2,0.2394,0.2681
GO:0001666,response to hypoxia,A3KLR9(Evidence code:IEA/Database source:UniProtKB:O09164|ens),ECSOD,BP,1,1 of 50,0.58,2,0.2394,0.2681
GO:0045211,postsynaptic membrane,F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens),CLSTN1,CC,1,1 of 51,0.58,1.96,0.2435,0.2716
GO:0006869,lipid transport,P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445),LDLR,BP,1,1 of 51,0.58,1.96,0.2435,0.2716
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,O62829(Evidence code:ISS/Database source:UniProtKB:P35813),PPM1A,BP,1,1 of 51,0.58,1.96,0.2435,0.2716
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,F1N780(Evidence code:IEA/Database source:UniProtKB:Q15375|ens),EPHA7,BP,1,1 of 52,0.58,1.92,0.2476,0.2758
GO:0004519,endonuclease activity,P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255),ANG2,MF,1,1 of 53,0.58,1.89,0.2516,0.28
GO:0003676,nucleic acid binding,A1A4K5(Evidence code:IEA/Database source:InterPro:IPR001604|I)P80929(Evidence code:IEA/Database source:InterPro:IPR001427), ENPP2 ANG2,MF,2,2 of 989,1.16,0.2,0.2553,0.2837
GO:0036464,cytoplasmic ribonucleoprotein granule,F1ME65(Evidence code:IEA/Database source:UniProtKB:A0A024RBH2),CKAP4,CC,1,1 of 54,0.58,1.85,0.2556,0.2837
GO:0042277,peptide binding,A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000164249),ERAP2,MF,1,1 of 56,0.58,1.79,0.2635,0.2922
GO:0043066,negative regulation of apoptotic process,F1MG91(Evidence code:IEA/Database source:InterPro:IPR015556)P45478(Evidence code:ISS/Database source:UniProtKB:P50897), SERPINB2 PPT1,BP,2,2 of 186,1.16,1.08,0.2668,0.2955
GO:0006959,humoral immune response,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 57,0.58,1.75,0.2675,0.2959
GO:0016055,Wnt signaling pathway,O19116(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879),SFRP1,BP,1,1 of 58,0.58,1.72,0.2714,0.2998
GO:0022900,electron transport chain,E1BBX5(Evidence code:IEA/Database source:GO:0009055),AOX2,BP,1,1 of 59,0.58,1.69,0.2753,0.3031
GO:0006650,glycerophospholipid metabolic process,Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8),PGP,BP,1,1 of 59,0.58,1.69,0.2753,0.3031
GO:0008202,steroid metabolic process,P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0753),LDLR,BP,1,1 of 59,0.58,1.69,0.2753,0.3031
GO:0009887,animal organ morphogenesis,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 60,0.58,1.67,0.2791,0.3062
GO:0045202,synapse,P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens),PRKAR1A,CC,1,1 of 60,0.58,1.67,0.2791,0.3062
GO:0070372,regulation of ERK1 and ERK2 cascade,F1N780(Evidence code:IEA/Database source:UniProtKB:Q15375|ens),EPHA7,BP,1,1 of 60,0.58,1.67,0.2791,0.3062
GO:0030036,actin cytoskeleton organization,O19116(Evidence code:IDA/Database source:),SFRP1,BP,1,1 of 64,0.58,1.56,0.2944,0.3222
GO:0005539,glycosaminoglycan binding,P21793(Evidence code:IEA/Database source:UniProtKB:P28654|ens),DCN,MF,1,1 of 64,0.58,1.56,0.2944,0.3222
GO:0006935,chemotaxis,A1A4K5(Evidence code:IEA/Database source:InterPro:IPR029881),ENPP2,BP,1,1 of 66,0.58,1.52,0.302,0.3301
GO:0071407,cellular response to organic cyclic compound,Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens),IGFBP5,BP,1,1 of 68,0.58,1.47,0.3094,0.3378
GO:0070085,glycosylation,Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503),CLN5,BP,1,1 of 70,0.58,1.43,0.3168,0.3455
GO:0016050,vesicle organization,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens),SORT1,BP,1,1 of 75,0.58,1.33,0.3348,0.3647
GO:0022407,regulation of cell-cell adhesion,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 76,0.58,1.32,0.3384,0.3682
GO:0031226,intrinsic component of plasma membrane,F1MYJ3(Evidence code:IEA/Database source:UniProtKB:P36269|ens)Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens), GGT5 TNFRSF21,CC,2,2 of 226,1.16,0.88,0.345,0.3749
GO:0004518,nuclease activity,P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540),ANG2,MF,1,1 of 79,0.58,1.27,0.3489,0.3788
GO:0050708,regulation of protein secretion,A6QQQ9(Evidence code:ISS/Database source:UniProtKB:Q9D312),KRT20,BP,1,1 of 80,0.58,1.25,0.3524,0.3821
GO:0005179,hormone activity,G3X6G7(Evidence code:IEA/Database source:UniProtKB:Q8VE43|ens),METRNL,MF,1,1 of 82,0.58,1.22,0.3593,0.3891
GO:0031625,ubiquitin protein ligase binding,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,MF,1,1 of 83,0.58,1.2,0.3627,0.3919
GO:0016829,lyase activity,Q58DK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456),ALAD,MF,1,1 of 83,0.58,1.2,0.3627,0.3919
GO:0016746,"transferase activity, transferring acyl groups",Q2KIW4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0012),LCAT,MF,1,1 of 85,0.58,1.18,0.3695,0.3988
GO:0016788,"hydrolase activity, acting on ester bonds",P46446(Evidence code:IEA/Database source:InterPro:IPR007036)A6H713(Evidence code:IEA/Database source:InterPro:IPR025483), ASPA LIPA,MF,2,2 of 240,1.16,0.83,0.3718,0.4007
GO:0042742,defense response to bacterium,P17453(Evidence code:IEA/Database source:UniProtKB-KW:KW-0044),BPI,BP,1,1 of 86,0.58,1.16,0.3729,0.401
GO:0006631,fatty acid metabolic process,F1MYJ3(Evidence code:IEA/Database source:UniProtKB:P36269|ens),GGT5,BP,1,1 of 86,0.58,1.16,0.3729,0.401
GO:0051260,protein homooligomerization,Q58DK5(Evidence code:IEA/Database source:UniProtKB:P13716|ens),ALAD,BP,1,1 of 88,0.58,1.14,0.3796,0.4068
GO:0005911,cell-cell junction,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,CC,1,1 of 88,0.58,1.14,0.3796,0.4068
GO:0051246,regulation of protein metabolic process,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens),LDLR,BP,1,1 of 576,0.58,0.17,0.3794,0.4068
GO:0050839,cell adhesion molecule binding,Q2TBL2(Evidence code:IBA/Database source:PANTHER:PTN000589024),CADM1,MF,1,1 of 89,0.58,1.12,0.3829,0.4099
GO:0045786,negative regulation of cell cycle,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,BP,1,1 of 90,0.58,1.11,0.3862,0.4129
GO:0048856,anatomical structure development,Q3SYW7(Evidence code:IBA/Database source:PANTHER:PTN001015480),SPARCL1,BP,1,1 of 617,0.58,0.16,0.388,0.4144
GO:0009617,response to bacterium,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 92,0.58,1.09,0.3927,0.4189
GO:0008152,metabolic process,Q0VD27(Evidence code:IEA/Database source:InterPro:IPR006439)Q58DK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)Q29444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q2T9S4(Evidence code:IEA/Database source:InterPro:IPR006349)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR017849|I)E1BIY5(Evidence code:IEA/Database source:InterPro:IPR000917|I)F1N2D5(Evidence code:IEA/Database source:InterPro:IPR000917|I)P46446(Evidence code:IEA/Database source:InterPro:IPR007036)Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q9MYM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326), ENOPH1 ALAD MANBA PGP ENPP2 SULF2 IDS ASPA CHIA GAA,BP,10,10 of 2613,5.78,0.38,0.3958,0.4217
GO:0005543,phospholipid binding,P00743(Evidence code:IEA/Database source:UniProtKB:P00742|ens),F10,MF,1,1 of 94,0.58,1.06,0.3992,0.4249
GO:0009888,tissue development,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 96,0.58,1.04,0.4056,0.4312
GO:0006457,protein folding,A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens),ERO1A ,BP,1,1 of 97,0.58,1.03,0.4088,0.4341
GO:0005813,centrosome,Q27965(Evidence code:ISS/Database source:UniProtKB:P0DMV9),HSPA1B,CC,1,1 of 99,0.58,1.01,0.4151,0.4397
GO:0031344,regulation of cell projection organization,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens),SEMA4D,BP,1,1 of 99,0.58,1.01,0.4151,0.4397
GO:0043410,positive regulation of MAPK cascade,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 102,0.58,0.98,0.4244,0.4491
GO:0016607,nuclear speck,F1ME65(Evidence code:IEA/Database source:UniProtKB:A0A024RBH2),CKAP4,CC,1,1 of 103,0.58,0.97,0.4275,0.4518
GO:0007005,mitochondrion organization,F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q6F3F9|ens),ADGRG6,BP,1,1 of 104,0.58,0.96,0.4305,0.4546
GO:0005773,vacuole,A7YWG4(Evidence code:IBA/Database source:PANTHER:PTN000140059),GGH,CC,1,1 of 109,0.58,0.92,0.4456,0.4699
GO:0008047,enzyme activator activity,E1BI28(Evidence code:IEA/Database source:InterPro:IPR028996),GM2A,MF,1,1 of 113,0.58,0.88,0.4573,0.4817
GO:0007165,signal transduction,A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000164501)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)F1ML75(Evidence code:IEA/Database source:InterPro:IPR000157)Q3SYW7(Evidence code:IEA/Database source:InterPro:IPR016359)Q08DN1(Evidence code:IEA/Database source:InterPro:IPR000488)O18739(Evidence code:IBA/Database source:PANTHER:PTN000142748), ERAP2 PTPRK IL1R1 SPARCL1 TNFRSF21 CTGF,BP,6,6 of 809,3.47,0.74,0.4584,0.4823
GO:0006520,cellular amino acid metabolic process,F1MYJ3(Evidence code:IEA/Database source:UniProtKB:P36269|ens),GGT5,BP,1,1 of 118,0.58,0.85,0.4716,0.4957
GO:0030155,regulation of cell adhesion,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 121,0.58,0.83,0.4801,0.504
GO:0051186,cofactor metabolic process,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 123,0.58,0.81,0.4856,0.5092
GO:0008283,cell proliferation,E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9),ENTPD5,BP,1,1 of 124,0.58,0.81,0.4883,0.5115
GO:0030659,cytoplasmic vesicle membrane,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens),SORT1,CC,1,1 of 126,0.58,0.79,0.4938,0.516
GO:0051301,cell division,Q0VC68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132),SEPT5,BP,1,1 of 126,0.58,0.79,0.4938,0.516
GO:0006412,translation,F1MYJ3(Evidence code:IEA/Database source:GO:0000048),GGT5,BP,1,1 of 130,0.58,0.77,0.5045,0.5267
GO:0045087,innate immune response,A6QL48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399),IL34,BP,1,1 of 131,0.58,0.76,0.5071,0.5288
GO:0043086,negative regulation of catalytic activity,F1MW38(Evidence code:IEA/Database source:GO:0004857),CRIM1,BP,1,1 of 137,0.58,0.73,0.5227,0.5444
GO:0004857,enzyme inhibitor activity,F1MW38(Evidence code:IEA/Database source:InterPro:IPR011061),CRIM1,MF,1,1 of 139,0.58,0.72,0.5278,0.5479
GO:0048468,cell development,P22444(Evidence code:IBA/Database source:PANTHER:PTN000218063),BMP3,BP,1,1 of 139,0.58,0.72,0.5278,0.5479
GO:0004175,endopeptidase activity,Q0V8B6(Evidence code:ISS/Database source:UniProtKB:O14773),TPP1,MF,1,1 of 139,0.58,0.72,0.5278,0.5479
GO:0019904,protein domain specific binding,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,MF,1,1 of 145,0.58,0.69,0.5427,0.5627
GO:0016773,"phosphotransferase activity, alcohol group as acceptor",Q1JPE3(Evidence code:IEA/Database source:InterPro:IPR018484),CARKL,MF,1,1 of 146,0.58,0.68,0.5451,0.5646
GO:0007049,cell cycle,Q0VC68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131),SEPT5,BP,1,1 of 151,0.58,0.66,0.5571,0.5764
GO:0043408,regulation of MAPK cascade,P22444(Evidence code:IBA/Database source:PANTHER:PTN000218063),BMP3,BP,1,1 of 152,0.58,0.66,0.5595,0.5782
GO:0043005,neuron projection,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,CC,1,1 of 154,0.58,0.65,0.5642,0.5824
GO:0050877,nervous system process,E1BI28(Evidence code:IEA/Database source:UniProtKB:Q60648|ens),GM2A,BP,1,1 of 155,0.58,0.65,0.5665,0.5841
GO:0030334,regulation of cell migration,A1A4K5(Evidence code:IEA/Database source:InterPro:IPR029881),ENPP2,BP,1,1 of 160,0.58,0.62,0.5779,0.5953
GO:0005815,microtubule organizing center,Q27965(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),HSPA1B,CC,1,1 of 164,0.58,0.61,0.5869,0.6038
GO:0005525,GTP binding,Q0VC68(Evidence code:IEA/Database source:InterPro:IPR016491|I),SEPT5,MF,1,1 of 165,0.58,0.61,0.5891,0.6054
GO:0045597,positive regulation of cell differentiation,O18739(Evidence code:IEA/Database source:UniProtKB:P29279|ens),CTGF,BP,1,1 of 167,0.58,0.6,0.5934,0.6092
GO:0045892,"negative regulation of transcription, DNA-templated",F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,BP,1,1 of 178,0.58,0.56,0.6166,0.6323
GO:0042127,regulation of cell proliferation,A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849), TNFRSF6B TNFRSF21,BP,2,2 of 309,1.16,0.65,0.6835,0.7001
GO:0030054,cell junction,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)Q28161(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965), PTPRK PKP1,CC,2,2 of 315,1.16,0.63,0.6876,0.7035
GO:0042981,regulation of apoptotic process,Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849)P22444(Evidence code:IBA/Database source:PANTHER:PTN000218063), TNFRSF21 BMP3,BP,2,2 of 317,1.16,0.63,0.689,0.7042
GO:0010628,positive regulation of gene expression,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens)P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens), RET LDLR,BP,2,2 of 331,1.16,0.6,0.6988,0.7134
GO:0007166,cell surface receptor signaling pathway,E1BEC6(Evidence code:IEA/Database source:InterPro:IPR017981)F1MJV6(Evidence code:IEA/Database source:InterPro:IPR017981), ADGRF1 ADGRG6,BP,2,2 of 344,1.16,0.58,0.708,0.722
GO:0005739,mitochondrion,A7MBI8(Evidence code:IBA/Database source:PANTHER:PTN000315253),NUDT9,CC,1,1 of 380,0.58,0.26,0.7271,0.7406
GO:0019899,enzyme binding,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,MF,1,1 of 405,0.58,0.25,0.7285,0.7413
GO:0009966,regulation of signal transduction,Q3ZBZ6(Evidence code:IEA/Database source:InterPro:IPR001863)F1MBN4(Evidence code:IBA/Database source:PANTHER:PTN001279849), GPC3 CXorf36,BP,2,2 of 593,1.16,0.34,0.7743,0.7861
GO:0006464,cellular protein modification process,F1MW08(Evidence code:IBA/Database source:PANTHER:PTN000289179)A5PJN2(Evidence code:IBA/Database source:PANTHER:PTN000289179), ERO1B ERO1A ,BP,2,2 of 565,1.16,0.35,0.7734,0.7861
GO:0003824,catalytic activity,Q9MYM4(Evidence code:IEA/Database source:InterPro:IPR011013)O62829(Evidence code:IEA/Database source:InterPro:IPR001932)Q9XSC6(Evidence code:IEA/Database source:InterPro:IPR014746)O62830(Evidence code:IEA/Database source:InterPro:IPR001932)A5PJH9(Evidence code:IEA/Database source:InterPro:IPR000845|I)F1N2D5(Evidence code:IEA/Database source:InterPro:IPR017849|I)Q58DK5(Evidence code:IEA/Database source:InterPro:IPR013785)G3MY87(Evidence code:IEA/Database source:InterPro:IPR011013)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR002591|I)E1BIY5(Evidence code:IEA/Database source:InterPro:IPR017849|I), GAA PPM1A CKM PPM1B UPP1 IDS ALAD MGAM ENPP2 SULF2,MF,10,10 of 1952,5.78,0.51,1,1
GO:0005102,signaling receptor binding,A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens)Q2TBL2(Evidence code:IEA/Database source:UniProtKB:Q9BY67|ens), SEMA4D CADM1,MF,2,2 of 385,1.16,0.52,1,1
GO:0003677,DNA binding,F1MSQ6(Evidence code:IEA/Database source:InterPro:IPR005819)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238), NEFH ANG2,MF,2,2 of 481,1.16,0.42,1,1
GO:0016192,vesicle-mediated transport,Q0VC16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931),MIA3,BP,1,1 of 277,0.58,0.36,1,1
GO:0051248,negative regulation of protein metabolic process,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 225,0.58,0.44,1,1
GO:0045893,"positive regulation of transcription, DNA-templated",F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 255,0.58,0.39,1,1
GO:0016772,"transferase activity, transferring phosphorus-containing groups",Q9XSC6(Evidence code:IEA/Database source:InterPro:IPR000749|I),CKM,MF,1,1 of 236,0.58,0.42,1,1
GO:0005654,nucleoplasm,F1MNL4(Evidence code:IEA/Database source:UniProtKB:Q92859|ens),NEO1,CC,1,1 of 315,0.58,0.32,1,1
GO:0009653,anatomical structure morphogenesis,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 217,0.58,0.46,1,1
GO:0042325,regulation of phosphorylation,E1BE60(Evidence code:IEA/Database source:InterPro:IPR008025|I),PPP1R14A,BP,1,1 of 330,0.58,0.3,1,1
GO:0003700,DNA-binding transcription factor activity,Q0VC23(Evidence code:IEA/Database source:InterPro:IPR029801),ATF6,MF,1,1 of 187,0.58,0.53,1,1
GO:0060548,negative regulation of cell death,O18739(Evidence code:IBA/Database source:PANTHER:PTN000142748),CTGF,BP,1,1 of 202,0.58,0.5,1,1
GO:0001932,regulation of protein phosphorylation,P00514(Evidence code:IEA/Database source:InterPro:IPR012198),PRKAR1A,BP,1,1 of 304,0.58,0.33,1,1
GO:0043085,positive regulation of catalytic activity,E1BI28(Evidence code:IEA/Database source:GO:0008047),GM2A,BP,1,1 of 229,0.58,0.44,1,1
